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Abstract
Real-time measurement, analysis, and control in microfluidic systems for personalized
medicine and designer materials
by
Peter L. Mage
The field of microfluidics has enabled the development of powerful tools for analyz-
ing and manipulating phenomena at the micro- and nano-scales, ranging from chemical
analysis of biological samples to controlled synthesis of colloidal materials. In this disser-
tation we explore four unique platforms for real-time microfluidic measurement, analysis,
and control systems with applications at the intersection of biomedicine and materials
engineering. First, we show that a real-time biosensor can be used to perform closed-
loop control of drug concentrations in the bloodstream of live animals. Second, we show
that a commercially available cell-sorting instrument can be used to sort heterogeneous
suspensions of synthetic microparticles based on shape using optical scattering measure-
ments, resulting in monodisperse microparticle suspensions with well-defined morphology.
Third, we report preliminary results for an image-based cell and microparticle sorter ca-
pable of sorting objects using two-dimensional high-speed microscopy and real-time image
analysis. Finally, we report a contamination-resistant microfluidic assay for quantitative
genetic detection based on real-time loop-mediated isothermal amplification, improving
the robustness of point-of-care pathogen detection techniques.
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Chapter 1
Introduction
1.1 Thesis goals and outline
The field of microfluidics has enabled the development of powerful tools for analyz-
ing and manipulating phenomena at the micro- and nano-scales, ranging from chemical
analysis of biological samples to controlled synthesis of colloidal materials. In this disser-
tation we explore several unique platforms for real-time measurement, signal processing,
and control in microfluidic systems with applications at the intersection of biomedicine
and materials engineering.
First, we describe a potential solution to the widespread clinical problem of patient-
to-patient variability in drug response. Here we report a system capable of directly con-
trolling circulating drug levels in the body in real-time. We achieve feedback-controlled
drug infusion using a microfluidic real-time biosensor that can continuously measure a
wide variety of drugs directly in the bloodstream. We demonstrate closed-loop control of
circulating concentrations of the chemotherapy drug doxorubicin in live rabbits and rats,
showing the ability to maintain virtually any concentration profile in the bloodstream
as a function of time. We demonstrate our system’s ability to regulate dosing across
1
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multiple animals with varying pharmacokinetics, and within a single animal undergoing
acute drug-drug interactions.
Second, we explore the unorthodox use of a microfluidic tool from the field of biology
to enable the production of well-defined colloids with applications as functional mate-
rials. We show that a commercially available fluorescence-activated cell sorter (FACS)
—a powerful and increasingly ubiquitous instrument used by cell biologists —can be
repurposed to sort synthetic colloidal microparticles based on shape. Using stretched
polystyrene microspheres as a model system, we demonstrate that microparticles exhibit
unique shape-dependent optical scattering profiles in FACS. We then use these signature
scattering profiles to sort and separate heterogeneous mixtures of particles with differ-
ent morphologies (spheres, discs, and ellipsoids with varying aspect ratios) with high
throughput (>1000 particles/s), purity, and yield, resulting in monodisperse suspensions
of particles with well-defined shapes.
Third, we report preliminary results for a novel integrated microfluidic device capable
of sorting particles and cells based on two-dimensional image features. Using high-speed
microscopy and automated 2D image analysis, we demonstrate automated sorting of
polymer microspheres and ellipsoids based on direct image detection of morphological
features such as size and shape. We also demonstrate an algorithm for analyzing and
sorting stem cell-derived retinal cells based on internal cell features.
Fourth and finally, we report an enzyme-based approach to eliminating carryover
contamination in real-time genetic pathogen detection assays based on loop-mediated
isothermal amplification (LAMP). Our contamination-resistant real-time LAMP assay
combines enzymatic elimination of carryover contaminants with DNA-intercalation-based
real-time amplification monitoring. Uracil-tagged carryover contaminants are degraded
with the uracil-DNA-glycosylase enzyme, and target amplification is monitored electro-
chemically in an integrated microfluidic device, enabling rapid discrimination of DNA
2
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samples with different amounts of pathogen DNA even in the presence of substantial car-
ryover contamination. This represents a critical enabling step toward robust, quantitative
real-time pathogen detection.
Because of the wide variety of topics covered in this dissertation, rather than us-
ing unified “Introduction,” “Theoretical Framework,” and “Conclusion” chapters, each
chapter has self-contained introductory material describing the motivation, prior work,
relevant theoretical discussions, and proposed future work related to that chapter’s topic.
3
Chapter 2
Closed-Loop Control of Circulating
Drug Concentrations in Live
Animals
2.1 Introduction
Although personalized medicine is typically perceived through the lens of matching
patients with the appropriate drugs, achieving the ideal dose for a given individual is
also critical. The optimal dose should maximize the efficacy of treatment while mini-
mizing the risk of harmful toxicity, a target range that is exceedingly narrow for many
widely-used drugs including chemotherapeutics [1,2], immunosuppressants [3,4], antipsy-
chotics [5], anticoagulants [6], aminoglycoside antibiotics [5], and others. Achieving this
optimal dose for drugs with narrow therapeutic windows is a major challenge for clin-
icians because of the profound variability with which patients respond to medication,
both from patient-to-patient and within the same patient over time [2, 7]. Response
to drug varies due to differences in both pharmacokinetics (PK) —describing how the
4
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body affects drug concentration over time through absorption, distribution, metabolism,
and excretion —and pharmacodynamics (PD), describing how the drug’s physiological
effect depends on effect-site concentration [8]. This variability in drug response, which
arises from a combination of genetic, physiological, and environmental factors [2], can
result in harmful under- or over-dosing, making it one of the principal problems in drug
development and clinical pharmacology.
To counter this unpredictability, clinicians presently use a variety of imperfect tools
that attempt to tailor drug dose to a specific patient’s needs. Most commonly, dosage
is selected by comparing the patient’s physiological parameters —such as sex, weight, or
body surface area (BSA) [9] —to dosage tables based on population-averaged PK/PD
data for that drug [10]. Unsurprisingly, this simple approach fails to account for a
large proportion of the clinically meaningful PK/PD variability observed across pa-
tients [1, 10, 11]. The recent explosion of “precision medicine” has encouraged the use
of more sophisticated personalization methods such as pharmacogenetic profiling, which
identifies specific polymorphisms in the individual’s genome that are known to cause
changes in drug metabolism, clearance, or susceptibility [12]. Unfortunately, pharmacoge-
netic approaches are time- and resource-intensive to develop and administer, making them
useful for only a select few drugs [13] and severely limiting their clinical deployment [14].
Moreover, methods such as pharmacogenetics and BSA-normalization do not correct
for physiological changes that may occur within a single patient over time, potentially
altering their response to drug over the course of treatment (e.g., exposure-dependent
pharmacokinetics, or comorbidities affecting ADME such as hepatic or renal failure, or
lowered serum albumin levels). To account for both patient-to-patient and intrapatient
variability, some drugs are accompanied by therapeutic dose monitoring (TDM), which
entails tracking the plasma levels of drugs and metabolites after initial drug adminis-
tration, and adjusting subsequent dosing accordingly based on PK/PD models [15, 16].
5
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Although TDM is the current standard of care for many narrow-therapeutic-index drugs,
it is constrained by slow, delayed measurements of plasma concentration at single time-
points, giving limited PK/PD insights and preventing responsive dose adjustment for
fast-acting drugs or rapidly changing disease states.
A much more powerful approach to personalized dosing would be to control the cir-
culating level of drugs in the body in a closed-loop manner. Toward this end, a small
number of closed-loop dosing systems have been developed since the 1950s for niche
applications involving narrow-therapeutic-index drugs, namely anesthesia delivery dur-
ing surgery [17–19] and cardiovascular drug infusion for maintenance of hemodynam-
ics [20–22]. More recently, the artificial pancreas platform has been used to regulate
blood glucose levels in diabetic patients through feedback-controlled insulin infusion [23].
Although these systems have shown improved therapeutic outcomes compared to manual
human-guided dosing [21, 24, 25], they cannot be applied to the vast majority of other
drugs. This is because all existing closed-loop dosing platforms perform control based
on readily measurable physiological effects of the drug (e.g. depth of anesthesia, blood
pressure, or blood glucose levels for the respective systems mentioned above) which act
as feedback for adjusting drug delivery. Many other drugs with narrow therapeutic win-
dows, such as chemotherapeutics or antipsychotics, have effects that cannot be measured
quickly enough to adjust infusion, preventing this sort of feedback control from being
implemented. A more general approach would be to control drug levels directly based on
measurements of in vivo drug concentration; however, the vast majority of drugs cannot
be measured in the body in real-time, making such an approach impossible to date. Nev-
ertheless, such control, if possible, would eliminate a major source of pharmacokinetic
uncertainty, namely, how drug infusion is related to the drug’s concentration-time profile
in the bloodstream.
Here we report the first medical technology that directly controls the circulating con-
6
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Figure 2.1: Scheme for closed-loop control of in vivo drug levels with CLINIC. As a
programmable infusion pump injects drug into the animal, the bloodstream is sampled
continuously by our real-time biosensor. The resulting electrochemical measurements
of drug concentration are analyzed by our control algorithm, which calculates the
infusion rate needed to maintain the desired circulating drug set-point at any given
time, and automatically adjusts the infusion rate accordingly.
centrations of drugs in the body in real-time. Our Closed-Loop Infusion for In vivo Con-
trol (CLINIC) system (Figure 2.1) continuously regulates the circulating concentration
of intravenous drugs by measuring the drug’s concentration in the bloodstream with a
real-time aptamer-based biosensor [26] and using a feedback control algorithm to contin-
uously modulate the rate of drug infusion, achieving the desired in vivo concentration at
minute time-scales. Crucially, in contrast to existing closed-loop dosing systems, CLINIC
controls infusion based on direct measurement of drug concentration in vivo, rather than
depending on delayed physiological indicators of drug activity as proxies for drug concen-
tration. This enables rapid and responsive control of drug plasma levels from patient to
patient and within the same patient over time, with no need for complex pharmacokinetic
modeling [10]. As a proof of concept, we used CLINIC to perform continuous closed-loop
dosing of the chemotherapy drug doxorubicin (DOX) in live rabbits and rats, demon-
7
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strating the capacity to achieve and maintain a wide range of concentration set-points in
the bloodstream as a function of time. We chose to use DOX because, while widely used
in cancer treatment, it is difficult to dose successfully in the clinic. The therapeutic out-
come of DOX treatment is closely tied to its plasma concentration profile over the course
of treatment, with efficacy dependent on total plasma exposure [27] and cardiotoxic side
effects correlated with peak plasma levels reached during drug infusion [28–31]. However,
DOX exhibits a very narrow therapeutic dose window [32], and patient-to-patient phar-
macokinetic response to DOX varies widely [27, 33, 34] even when normalized to body
surface area (BSA) —the current clinical standard for DOX dosing [11, 35]. Suboptimal
DOX dosing has been linked to a significant reduction in survival among breast cancer
patients [36].
2.2 Background and Theoretical Framework
2.2.1 Sensing requirements for feedback control
Performing feedback control of drug concentration requires a sensor that quantita-
tively measures drug levels in the body continuously (e.g., with high time resolution
relative to the relevant physiological processes, usually in the minute-range but poten-
tially shorter for applications such as neurological stimulation) and in real-time (e.g.,
with minimal measurement lag relative to the aforementioned time scales). A practi-
cal consequence of these requirements is that measurements must be performed directly
in the biological medium of interest, since traditional benchtop processing steps such
as centrifugation or affinity purification would introduce unacceptably long processing
times. Unfortunately, the majority of existing bioanalysis assays —such as the widely-
used enzyme-linked immunosorbent assay, or ELISA —provide only single time-point
8
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measurements [26]. This is because they require time-consuming sample processing and
analysis procedures, typically with multiple incubation and wash steps, making them im-
possible to use for real-time feedback control. Toward enabling continuous measurements,
other biosensor formats interrogate changes in physical properties of surface-bound re-
ceptors (typically antibodies) exposed to a sample flow containing analyte, providing
a continuous measurement of analyte concentration; examples of such an approach are
surface plasmon resonance and quartz crystal microbalance systems [37]. However, these
systems are cripplingly susceptible to nonspecific binding, making measurements all but
impossible in complex media such as blood [37]. This leaves a small number of analyte-
specific tools for measuring molecular species in vivo both continuously and in real-time,
namely, the pulse oximeter for monitoring blood oxygen content and oxidase-based elec-
trochemical sensors for blood glucose, lactate, glutamate, and cholesterol [37]. Unfor-
tunately, each of these examples is based on a target-specific enzyme interaction that
allows a quantitative readout of target concentration; such an enzymatic approach is not
generalizable to the vast majority of other analytes of interest.
Toward developing a general biosensor that could be used for in vivo feedback con-
trol, the Soh lab developed a sensor platform capable of real-time, continuous molec-
ular measurement directly in complex biological media. This platform combines three
key technologies. First, electrochemical aptamer probes provide instantaneous, re-
versible, and quantitative readout of target molecule concentration. These probes are
target-specific and can be generated for a wide variety of molecular targets [38]. Second,
a kinetic differential measurement scheme is utilized to eliminate baseline drift, re-
moving the need for baseline correction during post-processing and thus allowing truly
real-time measurements. Third, measurement is performed in a microfluidic blood
sampling device that enables analyte measurements directly in whole blood drawn di-
rectly from the bloodstream [26]. We will briefly discuss each of these technologies in
9
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turn.
2.2.2 Real-time biosensing with electrochemical aptamer probes
Electrochemical aptamer probes are a class of reagentless probes for real-time molec-
ular detection [39–41]. Aptamers are synthetic single-stranded DNA or RNA oligonu-
cleotides (generally < 100 bases long) that are generated through an in vitro evolution
process to bind specifically to some molecular target. Electrochemical aptamer probes
are based on a subset of aptamers whose three-dimensional conformation changes signif-
icantly upon target binding. This target-induced structure change can be measured by
probing the change in proximity that occurs between the 3’ and 5’ ends of the oligonu-
cleotide strand. This can be performed optically in solution, using a fluorophore-quencher
or FRET pair on the 3’ and 5’ ends of the strand. Alternatively, the conformation change
can be probed electrochemically using surface-tethered aptamers, wherein one end of the
aptamer is anchored to an electrode and the other end is tagged with a redox-active re-
porter which transfers electrons to the electrode through oxidation and reduction at the
appropriate potentials. We measure this redox activity using square-wave voltammetry
(SWV), which minimizes the effects of capacitive charging so that only faradaic electron
transfer due to redox reactions is measured. The amplitude of this faradaic current is
highly dependent on the average distance from the redox probe to the electrode surface;
hence, SWV interrogation of the redox-tagged surface-bound aptamer provides an in-
stantaneous electrical readout of target-binding-induced aptamer conformation changes.
Electrochemical aptamer-based sensing enables sensitive, specific, and real-time mea-
surement of target molecule concentrations. The performance of an electrochemical ap-
tamer for doxorubicin [26,42] is shown in Figure 2.2. First, the aptamer probe is sensitive
to DOX over a range of concentrations covering therapeutic levels in humans [43]; binding
10
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Figure 2.2: Characterization of electrochemical DOX aptamer performance, showing
probe response to target (left), probe specificity (center), and probe binding kinetics
(right). Adapted with permission from [26].
follows a Langmuir isotherm with an apparent dissociation constant of ∼ 0.8 nM in buffer
(Fig. 2.2, left). Second, the electrochemical DOX aptamer is highly specific to DOX over
other chemotherapy drugs commonly administered with DOX (Figure 2.2, center), al-
though it is known to bind to the structurally similar anthracycline daunorubicin [42].
Third, the DOX aptamer exhibits reversible drug binding with rapid binding kinetics as
shown in response to a 5-minute pulse of 600 nM DOX (Figure 2.2, right). The aptamer
exhibits an on-rate of kon = 3.0± 0.35 mM−1 min−1 and an off-rate of koff = 1.35± 0.05
min−1, enabling real-time readout of DOX pharmacokinetics [26].
2.2.3 Drift-free concentration tracking through kinetic differ-
ential measurement
To avoid signal drift over time, our real-time biosensor employs a differential mea-
surement scheme that self-corrects for baseline drift. Unlike differential measurements
that rely on a separate “reference” sensor, we perform differential measurements using a
single probe. We do this by exploiting the fact that the DOX aptamer, like many other
structure-switching electrochemical aptamers [38], can be used both as a “signal-on”
11
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Figure 2.3: The signaling polarity of the DOX aptamer is dependent on SWV pulse
width (1/2f , where f is SWV frequency) (left). By measuring at both signal-on
and signal-off SWV frequencies, a drift-free differential measurement can be obtained
(right). Adapted with permission from [26].
probe, where redox current increases with target binding, and as a “signal-off” probes,
where current decreases with target binding. The signaling magnitude and polarity of
electrochemical aptamers is dependent on the SWV interrogation frequency (the inverse
of the square-wave pulse width) [38], an effect arising from the kinetics of charge deple-
tion for surface-bound redox probes [38]. The DOX probe exhibits a signal-on response
in the presence of DOX when interrogated at high (≥100Hz) frequencies, and a signal-off
response to DOX at low (leq10Hz) frequencies (Figure 2.3, left). By interrogating the
probe at both signal-on and signal-off SWV frequencies, we obtain two current traces
with opposite target response polarity but similar baseline drift; subtracting these two
signals eliminates baseline drift while maintaining response to target. This kinetic differ-
ential measurement (KDM) strategy has two key benefits: (1) reduced baseline drift and
(2) enhanced signal magnitude relative to “common mode” noise (Figure 2.3, right) [26].
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(a) Diagram of the microfluidic real-time biosensor chip.
(b) Cross-sectional schematic of the CDF (compo-
nents not to scale).
(c) Simulated molecular transport across the CDF (left) and optical micrographs of electrode
fouling with or without the CDF (right).
Figure 2.4: Schematic and characterization of the continuous diffusion filter (CDF).
Adapted with permission from [26].
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2.2.4 Microfluidic continuous diffusion filter for long-term mea-
surement directly in whole blood
The third key technology in our real-time biosensor is a microfluidic continuous diffu-
sion filter (CDF) which allows target measurement directly in whole blood. The CDF pre-
vents occlusion of the aptamer-functionalized electrode surface by blood cells, platelets,
and other high-molecular-weight interferents (such as serum albumin and clotting fac-
tors) present in blood; such biofouling occurs rapidly on unprotected electrodes placed
directly in blood, causing significant baseline drift and diminished signal in response to
target. The CDF is formed within a microfluidic channel in the biosensor chip (Figure
2.4a) via vertical laminar flow stacking of a saline buffer layer (blue) on top a contin-
uous flow of blood (red), which may be drawn directly from a sample tube or from
an animal or patient’s bloodstream through a catheter (Figure 2.4b). The buffer layer
serves as a liquid-phase low-pass molecular weight filter between blood and the aptamer-
functionalized sensor electrode (located at the top of the channel). Low-molecular-weight
species, such as DOX, rapidly diffuse through the CDF and are detected at the electrode,
while only a small fraction of high-molecular-weight blood interferents are able to diffuse
to the electrode (finite element simulations of molecular transport across the CDF shown
in Figure 2.4c, left). Furthermore, the CDF prevents physical occlusion of the sensor by
blood cells and platelets (Figure 2.4c, right) [26].
In summary, our real-time biosensor achieves continuous quantitative measurements
of DOX directly in whole blood by integrating (i) electrochemical aptamer probes inter-
rogated with (ii) a kinetic differential measurement scheme in (iii) a microfluidic blood
sampling device that utilizes continuous diffusion filtering.
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2.3 Results and Discussion
2.3.1 CLINIC system overview
The CLINIC system controls in vivo drug concentrations by integrating our real-
time biosensor (RTB), a dose controller, and an intravenous infusion pump into a closed
feedback loop (Figure 2.1) which operates as follows. The RTB continuously samples
circulating blood directly from the bloodstream, transmitting drug concentration mea-
surements to the controller for real-time analysis. Based on the measured drug level,
the controller uses a feedback control algorithm to calculate the infusion rate required
to reach and maintain the desired concentration set-point. The controller then modu-
lates the infusion pump’s rate of drug administration accordingly. In this way, CLINIC
continuously adjusts drug infusion in response to measurements of drug concentration,
enabling it to control a wide range of concentration profiles in the bloodstream over time
with sub-minute resolution.
2.3.2 Real-time biosensing
The RTB achieves continuous, virtually lag-free measurements of in vivo DOX levels
by integrating electrochemical aptamer-based detection with a microfluidic blood sam-
pling system, described in detail above and in [26]. For this work, we dramatically reduced
the measurement lag of the RTB compared to our previous work by implementing two key
improvements. First, we wrote a real-time electrochemical analysis script in MATLAB
that converts raw electrochemical measurements to DOX concentration values on-the-fly.
Second, we optimized fluidic transport of blood from the animal to the device by using
short (< 10 cm) lengths of small-bore (∼ 200 µm ID) microcapillary tubing between a
venous catheter and the chip. Implementing these improvements enabled the controller
15
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Figure 2.5: Real-time biosensing of DOX in live rabbits. CLINIC’s real-time biosensor
has a point-to-point time resolution of 11 seconds and a measurement lag (δt) of 0.8
min (inset). Vertical dotted line indicates time of DOX bolus injection (0.93 mg/m2).
to respond to DOX fluctuations in vivo within 40 seconds (e.g., sensor-to-pump lag) with
a sampling interval of 11 seconds (Figure 2.5). Importantly, the aptamer probes in our
biosensor can readily be exchanged to measure a variety of target molecules [26], thereby
enabling CLINIC to potentially control a broad range of small-molecule drugs.
2.3.3 Feedback controller design, modeling, and tuning
CLINIC modulates the rate of drug infusion using a proportional-integral (PI) feed-
back control algorithm to achieve responsive, robust control of drug levels in the blood-
stream. The PI algorithm calculates infusion pump output U at any given time t as a
weighted sum of one term proportional (P) to the present error e(t) (difference between
measured and set-point concentrations) and another term proportional to the integral
(I) of the total error over time:
U(t) = kpe(t) + ki
∫ t
0
e(τ)dτ (2.1)
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Controller performance is wholly determined by two parameters, the proportional and
integral gains kp and ki, which determine the relative weight of the P and I terms.
Although physiological closed-loop control systems such as the artificial pancreas typically
rely on complex model-based control algorithms (e.g., [44]), we selected the PI feedback
algorithm for its simplicity and ability to respond rapidly to set-point changes while
achieving stable set-point tracking even in the presence of sensor lag.
To design and optimize the controller, we first modeled the entire feedback loop in
silico as a linear time-invariant system (Figure 2.6a). The central element of the system
model is a pharmacokinetic expression that empirically describes how DOX levels in the
bloodstream change over time, using a biphasic exponential decay model with a constant
dilution volume [45]. The model captures the dynamics of the rapid distribution (α) and
elimination (β) phases of DOX plasma clearance in rabbits (tα1/2 = 2 min, t
β
1/2 = 18 min)
while ignoring the γ-phase (tγ1/2 = 15 hr) [45], which is too slow to meaningfully affect our
system. To build this model, we experimentally determined average α- and β-phase half-
lives of DOX by using the RTB to measure circulating DOX levels in rabbits during DOX
administration. We then empirically tuned the model so that it accurately simulated in
vivo concentrations for a given DOX input (Figure 2.6b). We finally added components to
the system model describing the temporal behavior of the RTB, the infusion pump, and
the feedback controller, allowing us to simulate operation of the entire CLINIC system.
To ensure that simulations using our system model matched real-world CLINIC be-
havior, we measured the step response of the controller using a simple, untuned propor-
tional (P only, ki = 0) control algorithm. When deployed in a rabbit, the controller had
the underdamped response typical of untuned P control for a second-order process, with
a steady-state error due to sensor lag (Figure 2.6c, top ). Simulating the same control
algorithm with our system model yielded quantitatively similar control behavior (Figure
2.6c, bottom), validating the model’s usefulness for describing CLINIC performance.
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(a) Feedback loop model (b) Pharmacokinetic simulation
(c) Controller simulation perfor-
mance
(d) Result of PI controller tuning
Figure 2.6: Simulation and tuning of CLINIC feedback controller
Using our system model, we tested the performance of different PI control settings
to determine an optimal controller design for CLINIC use in vivo. Notably, simulations
showed that controller performance was sufficient without a derivative (D) term (used in
the more common PID algorithm), which would have made the system more susceptible
to high-frequency noise in the RTB measurements. We used our system model and
controller tuning software to determine an optimal set of kp and ki parameters that
balanced controller response time and stability (Figure 2.6d). We then utilized these
gain parameters in CLINIC’s tuned PI controller.
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2.3.4 Closed-loop control of DOX levels in live rabbits and rats
Using this algorithm, CLINIC achieved stable, prolonged feedback control of circu-
lating levels of DOX in live, conscious New Zealand White rabbits (Figure 2.7). CLINIC
responded rapidly to changes in set-point (Figure 2.7, top), reaching 95% of the set-point
concentration in 7.52.9 minutes from the start of controlled infusion, and remained within
20% of the set-point throughout the experiment (details in supplementary online text).
We note that these set-points, representative of typical therapeutic concentrations for
humans, are maintained for durations similar to those used during clinical infusions [43].
We also used CLINIC to maintain other dosing profiles as a function of time, including
concentration ramp-ups and ramp-downs and arbitrary combinations of ramps and holds
(Figure 2.7, middle and bottom, respectively). In all instances, CLINIC maintained
stable feedback control with minimal oscillation.
To demonstrate our platform’s capacity for robust closed-loop feedback control across
species, we used CLINIC in live, anesthetized Sprague-Dawley rats. We chose this species
because rats have DOX plasma clearance times markedly different from the rabbit model
but nearly identical to those of humans [43,46–48]. We obtained optimal P and I control
parameters for infusion in rats by adapting our in silico model to account for this cross-
species difference in pharmacokinetics. By adjusting only the P and I control parameters
without further modifications to the CLINIC system, we achieved feedback performance
in rats that was essentially equivalent to that demonstrated in rabbits, reaching 95% of
the concentration set-point within 8.6 min (Figure 2.8). Of note, DOX plasma levels
returned to an elevated baseline concentration at the end of infusion because DOX has
considerably longer α- and β-phase circulation half-lives in rats.
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Figure 2.7: Closed-loop feedback control of doxorubicin. CLINIC accurately maintains
in vivo drug concentrations (blue dots) at the desired set point (orange line) with a
response time of 5-10 minutes in live, conscious New Zealand White rabbits. A variety
of concentration profiles can be realized continuously as a function of time. Start of
control indicated by orange arrows.
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Figure 2.8: Closed-loop feedback control of doxorubicin. CLINIC accurately maintains
in vivo drug concentrations (blue dots) at the desired set point (orange line) with a
response time of 5-10 minutes in live, anesthetized Sprague-Dawley rats. A variety
of concentration profiles can be realized continuously as a function of time. Start of
control indicated by orange arrows.
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2.3.5 Compensating for animal-to-animal pharmacokinetic vari-
ability with CLINIC
We next applied CLINIC to the widespread clinical problem of pharmacokinetic vari-
ability in chemotherapy dosing, both across individuals and in the same individual over
time [2, 7]. First, we employed CLINIC to perform real-time dose compensation for in-
dividual differences in DOX pharmacokinetics across multiple rabbits. To quantify the
extent of pharmacokinetic variability, we administered three different rabbits with an
identical BSA-adjusted dose of DOX. We performed a constant one-hour infusion regi-
men at 11.5 mg/m2/hr, equivalent to typical human therapeutic dosing [35]. Real-time
biosensor measurements revealed pronounced variability in plasma levels of DOX across
individual rabbits during this “open-loop” dosing, even though the dosing regimens were
normalized by BSA —the current clinical standard (Figure 2.9A). Only Rabbit 3 achieved
the desired plasma level and stayed in the target concentration range for 80% of the in-
fusion period (white windows in Figure 2.9A). The steady-state values of plasma DOX
levels in Rabbits 1 and 2 were either below or above the desired level, staying within
the target concentration range for only 31% and 12% of the infusion period, respectively
(Figure 2.9A). The biosensor was independently calibrated immediately prior to each in-
fusion, ensuring that differences in measured plasma levels were due to pharmacokinetics
and not sensor variability.
In contrast to open-loop dosing, CLINIC automatically and dynamically adjusted
infusion rates to achieve the desired DOX concentration (Figure 2.9B). Under closed-
loop infusion control, Rabbits 1 and 2 remained within the target concentration range
81% and 96% of the time, respectively (Figure 2.9C), a significant improvement compared
to open-loop BSA-adjusted dosing. Importantly, the same P and I control parameters
were used for all animals, demonstrating that CLINIC can optimize therapeutic dosing
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Figure 2.9: CLINIC maintains stable plasma drug levels in animals with varying
pharmacokinetics. (A) Pharmacokinetic variability results in distinctly different DOX
plasma concentrations in three different animals over the course of infusion; only Rab-
bit 3 remains in the target range (white band) for the majority of the infusion period
(demarcated by arrows). (B) CLINIC maintains the desired DOX plasma concentra-
tion set-point (orange dashed line) in both Rabbits 1 and 2. (C) Closed-loop feedback
control results in a far greater proportion of time spent in the target concentration
range, independent of pharmacokinetic variability.
without a priori knowledge of an individual’s pharmacokinetics.
2.3.6 Correcting for acute drug-drug interactions with CLINIC
Finally, we used CLINIC to automatically optimize dosing during acute drug-drug
interactions, which can cause rapid, unpredictable, and dangerous pharmacokinetic dis-
turbances [7]. Specifically, we co-administered the widely-used chemotherapy drug cis-
platin (CDDP) to rabbits prior to DOX infusion [49], leading to a drug interaction
known to significantly extend DOX’s plasma half-life and increase its peak plasma con-
centration, presumably due to CDDP-induced changes in liver and kidney function [50].
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This interaction was clearly evident when we compared the plasma concentration pro-
file of DOX during DOX-only infusion (Figure 2.10A, left) to that of DOX during
DOX+CDDP co-administration in the same rabbit one week later (Figure 2.10A, cen-
ter). Co-administration led to significantly higher plasma levels of DOX over the course
of infusion, even though an identical BSA-adjusted DOX dose was given in both cases.
This open-loop dosing resulted in only 34% time in the target concentration range dur-
ing co-administration, dramatically worse than the 95% for DOX infusion alone (Figure
2.10A, right). In contrast, closed-loop dosing with CLINIC automatically maintained
DOX at precisely the desired concentration in the presence of CDDP (Figure 2.10B),
increasing percent time in the target concentration range to 97% during DOX+CDDP
co-administration.
2.3.7 Discussion and Conclusion
In this work, we have demonstrated CLINIC’s potential to enable precise therapies
through closed-loop control of drug concentrations in vivo. As a proof-of-concept, we di-
rectly controlled the circulating levels of the chemotherapeutic agent DOX in live rabbits
and rats, with the ability to reach and maintain a broad range of concentration set-points
in the bloodstream as a function of time. Our system automatically adapts drug delivery
to individual animals’ physiology, compensating in real-time for pharmacokinetic vari-
ability and drug-drug interactions to enable optimal therapeutic dosing. We have shown
that CLINIC can be readily adapted to regulate DOX levels in two mammalian species
with dramatically different physiological and pharmacokinetic characteristics. Based on
this, we believe that CLINIC could be successfully adapted to control DOX levels in hu-
mans with minimal changes to the system. Moreover, because CLINIC uses a real-time
biosensor based on aptamers that can readily be exchanged to measure other molecular
24
Closed-Loop Control of Circulating Drug Concentrations in Live Animals Chapter 2
Figure 2.10: CLINIC automatically corrects for acute drug-drug interactions. (A)
DOX pharmacokinetics in rabbits (left) is markedly altered by co-administration of
cisplatin (CDDP; middle), resulting in plasma concentrations that exceed the target
range (right). (B) CLINIC automatically corrects for this effect and achieves a stable
set-point (middle), maintaining the target concentration for the entire duration of
infusion (right). Arrows indicate start and end of DOX infusion.
targets [26], it offers a generalizable platform for closed-loop control of a broad range of
drugs in living subjects.
Although this work demonstrates CLINIC’s therapeutic potential, there are a number
of limitations to the results of this study. We did not perform therapeutic endpoint studies
to determine whether our dosing approach improves efficacy or diminishes toxicity in an
animal model over the course of long-term treatment. However, because the efficacy
and toxicity of DOX are known to be correlated with plasma drug levels, such studies
are a logical next step. We also note that our system only regulates levels of unbound
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drug in the circulatory compartment, which, while clinically relevant for DOX and many
other drugs, neglects the fact that there is often a complex pharmacokinetic relationship
between plasma levels and effect-site concentration (and therefore efficacy) for other
drugs.
There are several areas of improvement possible for the CLINIC platform. First,
CLINIC can actively increase circulating DOX levels by accelerating infusion, but con-
centration decreases are dependent on the animal’s physiological drug-clearance rate.
However, for drugs with injectable reversal agents [51, 52], our system could readily be
adapted to perform active reduction of effective drug concentrations. Second, CLINIC is
presently designed to control infusion based on measurements of unbound drug molecules
in the blood. However, for many drugs, levels of metabolites and protein-bound drug
are also important indicators of pharmacological activity. Future versions of our sys-
tem could integrate multiple aptamer probes to control infusion based on simultaneous
measurement of not only free drug but also its metabolites and drug-protein complexes.
Third, we demonstrated stable drug control over multiple-hour time periods, suitable for
acute clinical applications. Previously, similar aptamer probes have been shown to be
chemically stable for several weeks [53]. Based on these results, we anticipate that control
with CLINIC could be extended over much longer time frames to enable treatment of
chronic conditions.
2.4 Conclusion
Our results controlling DOX suggest that CLINIC would be particularly useful for
drugs with narrow therapeutic windows, a major class of therapeutics with unresolved
challenges for dosing due to patient-to-patient variability [5]. Another potentially power-
ful application of CLINIC is for dosing drugs with fast pharmacokinetics and pharmaco-
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dynamics (e.g., propofol [54]), especially in situations where patient physiology changes
rapidly and unpredictably (e.g., during surgery or trauma care). In its present con-
figuration, CLINIC is an ex vivo system that would be well-suited for use in clinical
settings, but future iterations of our platform could incorporate implantable sensors [55]
and infusion devices [56] to enable continuous, minimally-invasive dose regulation for
chronic conditions. We envision that future versions of CLINIC could eventually be
used to control drug delivery not only based on measurement of in vivo drug levels, but
also by continuously monitoring the body’s response to drug in the form of circulating
biomarkers. This ability would be a first step toward direct closed-loop regulation of
physiological processes, potentially making CLINIC a powerful tool for next-generation
precision medicine.
2.5 Experimental Methods
2.5.1 Study design
The objectives of our study were twofold. First, we sought to demonstrate the proof-
of-concept capability to directly control circulating concentrations of therapeutic agents
in live New Zealand White rabbits and live Sprague-Dawley rats, using DOX as a model.
Second, we aimed to use this closed-loop control to adjust DOX administration in rabbits
to automatically compensate for pharmacokinetic variability, both from animal-to-animal
and within the same animal due to drug-drug interactions. To evaluate controller perfor-
mance, DOX concentrations were measured directly in the animals’ bloodstream using
our real-time biosensor. To evaluate pharmacokinetic variability, we measured the cir-
culating concentration of DOX in multiple rabbits undergoing identical BSA-adjusted
infusions of DOX, as well as in rabbits undergoing identical infusions of DOX before and
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after CDDP administration (details in Results). For pharmacokinetic variability exper-
iments, rabbits were used instead of rats because drug monitoring and control can be
performed as a non-terminal survival procedure in rabbits, enabling comparison across
multiple experiments in the same animal. Individual animals were selected randomly for
each experiment. Blinding was not applicable to this study. Replication conditions for
each experiment are defined and described in Results.
2.5.2 Sensor fabrication
Sensor fabrication (Figure 2.11) is described in detail in [26]. Briefly, two Borofloat
glass wafers (University Wafer Inc.), each 10 cm in diameter and 700 µm thick, were
cleaned by sequential immersion in acetone, isopropanol and deionized water. Gold
working electrodes and platinum counter and reference electrodes were photolithograph-
ically patterned onto the top wafer and electron beamevaporated (VES 2550, Temescal)
to a thickness of 300 nm on 20-nm titanium adhesion layers. Subsequently, a CNC mill
(Flashcut CNC) with 1.1-mm diamond bit (Triple Ripple, Abrasive Technology) was used
to drill fluidic vias (two inlets, one outlet) in the top wafer. The top and bottom wafers
were diced (DISCO) into device pieces with dimensions of 58 mm 11 mm and 53 mm 11
mm, respectively. The 500-µm-wide top (buffer) and bottom (blood) flow channels were
both cut from a 250-µm-thick polydimethylsiloxane (PDMS) sheet (BISCO Silicones,
Rogers Corp.) using a laser cutter (Speedy 100, Trotec).
The blood channel was first bonded to the diced bottom glass substrate via 10-s
corona-ozone treatment (BD-20AC, Electro-Technic Products Inc.). The buffer channel
was then bonded to the blood channel. To prevent clot formation in the sensor chips
during exposure to whole blood, a commercial heparin surface-coating kit [57, 58] (Har-
vard Apparatus) was used to treat the inner surface of the assembled blood and buffer
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Figure 2.11: Exploded diagram of MEDIC chip components and assembly.
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channels as well as the bottom glass substrate. Meanwhile, electrochemical cleaning of
the gold working electrodes was performed on the top electrode glass substrate following
the protocol in [26]. The heparin-treated bottom glass substrate-blood channel-buffer
channel assembly and cleaned top electrode glass substrate were both ozone treated in a
UV ozone cleaner (Novascan) for 10 minutes and subsequently bonded. Alignment was
performed under a standard inverted microscope via an xyzq stage (Newport Corp.) and
vacuum chuck. Fluidic port connectors were glued onto the device with 5-min epoxy
(ITW Devcon), readying the chip for probe immobilization.
2.5.3 Aptamer probe preparation and immobilization
The DOX-specific aptamer probe was synthesized by Biosearch Technologies with the
following sequence: 5’-(HS-(CH2)6)3-ACCATCTGTGTAAGGGGTAAGGGGTGGT-MB-
3’. Design rationale for this probe is described in detail in [26]. Notably, we replaced
the mono-thiol linker used in [26] with a more robust trithiol anchor, extending the sen-
sor lifetime and thermal stability compared to mono-thiol linkers alone [53]. The probe
was tri-thiolated at the 5’ end to facilitate self-assembly on the gold working electrodes,
and conjugated with a methylene blue (MB) redox label at the 3’ end to enable target
binding-induced charge transfer modulation. Probe preparation and immobilization were
otherwise identical to [26].
2.5.4 Fluidic instrumentation
All flow to and from CLINIC was controlled via syringe pumps (PhD 2000, Harvard
Apparatus). The sensor chip input port was connected to a 24-gauge intravenous catheter
(Beckton Dickinson) for animal studies via a 15-cm length of 0.20-mm inner diameter (ID)
fluorinated ethylene propylene (FEP) tubing (IDEX). A 10-ml syringe loaded with 1 SSC
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supplemented with 100 U/ml heparin was placed in a pump and connected to the buffer
port on the sensor chip via a 30-cm length of Tygon tubing (Saint-Gobain Performance
Plastics), with 1.78-mm outer diameter (OD) and 1.02-mm ID. The sensor chip output
port was connected to a primed 20-ml “waste” syringe placed in a second pump via 1.65-
mm OD and 0.762-mm ID silicone tubing (NewAge Industries). To monitor flow rates in
real-time, we used a flow meter (Mitos Flow Rate Sensor, Dolomite Microfluidics) in-line
between the output port and waste syringe pump. The buffer layer was established by
engaging the buffer pump at 0.331 ml/hour. Simultaneously, sample was continuously
drawn into the device by engaging the waste pump at 1.654 ml/hour.
2.5.5 Voltammetry
Electrochemical measurements were conducted with a PalmSens EmStat2 USB-connected
potentiostat (Palm Instruments BV). Sensor chips were connected to the potentiostat via
an 8-pin card edge connector. Square-wave voltammetry (SWV) scans were performed
at interrogation frequencies of 10 Hz and 100 Hz, with a square-wave pulse amplitude
of 30 mV and potential steps of 10 and 1 mV, respectively, resulting in an average scan
period of 5.5 s. A potential range of 160 mV to -240 mV (vs. Pt) was used to capture
the full redox current peak of MB. In cases where reference potential drift occurred, the
scan range was adjusted until the MB redox peak occurred in the center of the range.
2.5.6 Sensor characterization and calibration
To convert electrochemical current measurements to concentration values, we ob-
tained a dose-response curve by exposing the sensor chip to DOX (LC Laboratories)
concentrations ranging from 250 nM to 8 µM in rabbit whole blood flowing at the rate
described above. At each concentration, the sensor signal was permitted to equilibrate
31
Closed-Loop Control of Circulating Drug Concentrations in Live Animals Chapter 2
and the subsequent 50 points were averaged as the reported values. A dose-response
curve was obtained by fitting signal gain to a Langmuir isotherm, resulting in an appar-
ent dissociation constant (Kd) of 1.682± 0.030 µM (mean±SD).
2.5.7 Real-time analysis and control program
To facilitate real-time measurement, dose calculation, and pump control, a custom
analysis and control program was written in MATLAB (Mathworks). The program per-
forms three key functions: (1) retrieving and converting raw electrochemical data from
the potentiostat into concentration measurements, (2) calculating the necessary infusion
rate —based on these measurements and the user-input concentration set-point —using
a discrete implementation of the parallel PI control algorithm, and (3) communicating
with the infusion pump to adjust the drug infusion rate. In addition, the program pro-
vides a real-time graphical plotting interface enabling the user to observe concentration
measurements and controller output.
2.5.8 Control system modeling, simulation & tuning
The dynamical systems simulation software Simulink (Mathworks) was used to model
the feedback loop comprising the animal pharmacokinetics, real-time biosensor, and PI
controller, as well as all relevant transport and signal processing delays in the system 2.12.
Pharmacokinetics of DOX in rabbits and rats was modeled as a biphasic concentration
decay with decay constants α and β and respective weighting constants Wα and Wβ:
C(t)
C0
= Wα exp(−αt) +Wβ exp(−βt) (2.2)
where C(t) is drug concentration in the bloodstream at time t and C0 is the initial
concentration. A constant blood dilution volume was incorporated to account for dilution
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Figure 2.12: Simulink model used for controller tuning.
of drug in the bloodstream. To model the real-time biosensor, we incorporated terms to
account for the fluidic transport delay from the animal’s bloodstream to the sensor, as
well as the sensor’s fixed sampling rate and its temporal response to changes in DOX
concentration (fitted from sensor step-response data).
With the full feedback loop described in the model, we used Simulink’s built-in PID
tuning functionality to determine P and I parameters that maximized response time
(rapid rise time) and minimized both overshoot and oscillation about the set-point. To
account for uncertainties in the model, it was necessary to determine a correction factor
so that these in silico tuned parameters would result in similar control performance when
implemented in vivo. To do this, we performed in vivo feedback control using specific
sets of “training” control parameters. We then manually adjusted the control parameters
in the Simulink model until we found a set of P and I parameters that resulted in in silico
performance that was quantitatively similar to the in vivo training data. We compared
the in vivo control parameters to the in silico control parameters that produced the same
observed performance, and subsequently calculated a correction factor. The final control
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algorithm was implemented in a discrete form, with a fixed sampling time of 5 seconds.
2.5.9 Live animal studies
Live animal studies using New Zealand White rabbits were performed according to
our protocol titled “In vivo small molecule detection (rabbits),” approved by the Univer-
sity of California, Santa Barbara (UCSB) Institutional Animal Care and Use Committee
(IACUC) and assigned protocol number 859. All rabbits used in this work were male
(n=14) and purchased from Charles River Laboratories. Rabbits were acclimated to the
facility for at least one week after arrival and observed for abnormal health conditions
before experiments were performed. Rabbits were treated with aspirin (CVS) (10 mg/kg
P.O. cumulative) and clopidogrel (Henry Schein) (10 mg/kg P.O. cumulative) over the
four days leading up to and including the day of the experiment to prevent formation of
clots in the catheter, tubing, and chip during blood draws [59]. Immediately prior to the
experiment, rabbits were partially sedated with acepromazine (Henry Schein) (1 mg/kg
I.M.). Rabbits were placed in rabbit restrainers to prevent them from damaging or dis-
turbing their catheters. To facilitate catheter access to the marginal ear veins, the rabbits’
ears were shaved and a topical anesthetic (EMLA lidocaine/prilocaine cream, MedVet)
was applied 15 minutes prior to catheterization. Cannulation was performed in the
marginal vein of both ears (Insyte Autoguard Shielded IV Catheter, Becton-Dickinson).
To prevent clot formation in the catheters, tubing, and sensor chip, an initial dose of
300 IU/kg heparin (SavMart) was injected via each catheter, followed by hourly doses
of 150 IU/kg administered via the right ear vein catheter. Following catheterization and
heparin administration, 2.5 mL of blood was drawn for sensor calibration. After calibra-
tion, capillary tubing (0.008” ID FEP tubing, IDEX) was inserted into the left ear vein
catheter and blood was drawn continuously from the catheter through the sensor chip
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at a rate of 1.323 ml/hr. Bolus injections, continuous infusions, and controlled infusions
of DOX (LC Laboratories) and CDDP (Western Medical Supply) were all administered
via the right ear vein catheter. Continuous and controlled infusions were injected by
a syringe pump from a 5 ml syringe connected to the catheter via a 30-cm length of
polytetrafluoroethylene (PTFE) tubing (Cole-Parmer), with 0.76-mm OD and 0.30-mm
ID. The catheters for infusion and measurement were placed such that injected drug
passed through the heart and into circulation before being withdrawn for measurement.
At the conclusion of experiments, rabbits were euthanized via intravenous Euthasol (Vir-
bac Animal Health) injection if they received CDDP during the experiment and/or their
cumulative dose of DOX over all experiments exceeded 1 mg/kg; otherwise, they were
returned to their cages for recovery and use in subsequent experiments.
Live animal studies using Sprague-Dawley rats were performed under our “In vivo
small molecule detection” protocol, similarly approved by the UCSB IACUC and assigned
protocol number 824. All rats used in this work were male (n=6) and purchased from
Charles River Laboratories. The rat surgical setup protocol, including anesthetization,
catheter placement, heparin administration, DOX bolus administration, and euthanasia,
is identical to the protocol described in [26], with the addition that controlled infusion of
DOX was administered into the right jugular vein catheter using the same setup described
above for rabbits.
Controlled infusions of DOX for rats and rabbits were given at a concentration of 2
mM. For continuous open-loop infusion experiments in rabbits, DOX concentration and
volume infusion rate were selected such that all rabbits would receive the same BSA-
adjusted dose at an infusion rate of 11.5 mg/m2/hr for exactly one hour. Body surface
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area (BSA, m2) for dose normalization was calculated according to the equation
BSA =
9.9×m2/3
10, 000
(2.3)
as described in [60], where m is the animal’s mass in grams. CDDP, when administered,
was given to a total dose of 4 mg/kg as a single bolus injection at a concentration of 1
mg/ml, 2-4 hours prior to DOX infusion.
2.5.10 Step-response rise time calculation and infusion analysis
To quantify controller performance in vivo, we calculated the time required for the
controller to reach 95% of its set-point step response, with starting time defined as when
feedback control was activated. For these calculations, sensor data was smoothed to
minimize the impact of high-frequency noise. Step response profiles from four separate
rabbit experiments were analyzed to calculate mean and standard deviation.
In each rabbit, the plasma concentration profile was characterized by a rapid rise
(drug distribution phase, 1-5 minutes after start of infusion), a subsequent slow linear
increase in concentration over the remainder of the infusion time (quasi-steady state,
qSS, 6-60 minutes after start of infusion), and a rapid decrease to a slightly elevated
baseline concentration after cessation of infusion. We defined the target concentration
range as a window whose center is the average concentration during the qSS phase across
all three animals and whose width is the average standard deviation of the qSS-phase
concentration in a single animal. We calculated this target range to be 0.5 µM ± 0.1
µM. Percent time in target range was defined as the percentage of the qSS phase during
which the measured in vivo concentration was within the target concentration range.
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Chapter 3
Shape-based Separation of Synthetic
Microparticles with a
Fluorescence-Activated Cell Sorter
3.1 Introduction
1 Synthetic microparticles are a major class of “designer” materials [61], with applica-
tions ranging from drug delivery [62–64] and biomedical imaging [65] to directed assembly
of photonic colloids [66] and other functional materials [67–69]. Successful synthesis of
well-defined colloidal materials for these applications requires tight control over not only
their chemical properties, but also their physical attributes such as microparticle size and
shape [63] As a result, a large body of work related to controlled polymer microparticle
synthesis has been developed over the past several decades. Complex schemes relying on
droplet microfluidics [70–73], flow lithographic methods [71, 74, 75], and electrohydrody-
1At the date of compiling this thesis, March 17, 2016, this work is still in progress. The contents are
thus presented as preliminary results.
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namic inkjet printing [76] have been developed, all boasting various degrees of control over
particle shape, size, and composition. However, such approaches are typically difficult
to develop and operate, requiring specialized devices for any desired particle, prevent-
ing their adoption on a large scale. In addition, these approaches are often severely
limited by their particle generation throughput. On the other end of the synthesis spec-
trum are facile and scalable methods such as emulsification in bulk mixtures undergoing
mechanical agitation or sonication [61] or precipitation reactions [77]; however, these
approaches typically result in heterogeneous, polydisperse colloidal mixtures [61, 67, 78].
Aggregation-based methods, wherein clusters of monodisperse “building blocks” can be
formed through templated [67] or surface-tension driven [79] self-assembly, can also be
used to generate clusters of specific size and shape, but similarly require downstream
purification.
The heterogeneity resulting from scalable, facile synthesis approaches can be overcome
with downstream fractionation and sorting, enabling purified populations of microparti-
cles with specific desired morphologies to be obtained. A wide range of techniques for
separating particles based on their physical characteristics have been reported [80]. The
majority of these rely on intrinsic differences in the particles’ density, volume, or hydrody-
namic radius to achieve separation. Density gradient centrifugation is the most common
example of such an approach. Isopycnic centrifugation can be used to enrich particles
based on their density, but is incapable of separating particles based on shape. Rate-
zonal centrifugation can separate particles based on mass differences, but can only achieve
shape-based separation for radically differing shapes (e.g., needles vs. spheres), with poor
resolving power and purity [81, 82]. More sophisticated electrophoretic techniques have
also been used to separate nanoparticles based on shape (hydrodynamic radius) [83],
but require coating the particles with charged functional groups. Specialized microfluidic
tools have also been developed to sort particles based on their hydrodynamic or electroki-
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netic properties. Deterministic lateral displacement (DLD) can separate particles based
on volume and shape (exploiting the fact that particles with different shape have different
hydrodynamic radii), but are physically limited to very low flow rates and consequently
have very low particle throughput [84, 85]. Other techniques utilizing electrokinetics are
similarly throughput- and purity-limited [86]. Faster systems using inertial microfluidics
have been shown to passively separate isovolumetric ellipsoid particles based on aspect
ratio [87] at comparatively high fluid volume throughput (40-80 µl/min, demonstrated
with 1 × 106 particles/ml), but with limited separation purity and separation resolu-
tion. More troublingly, the use of such microfluidic systems defeats the purpose of using
facile and scalable emulsion-based synthesis techniques, because they require specialized
microfluidic devices that are difficult to design and operate, they necessitate extensive
tuning and even redesign depending on the target particle system to be sorted, and have
poor scalability. There is thus a pressing need for a separation strategy that can achieve
high sorting sensitivity and purity, while preserving the scalability and throughput of
facile emulsion-based synthesis.
Toward this end, we report the first shape-based sorting of synthetic microparticles
using elastic optical scattering measurements performed in a commercial fluorescence-
activated cell sorter (FACS). Optical scattering is a well-characterized method for non-
destructive characterization of synthetic microparticle morphology [88–90], but has never
been used for active sorting or enrichment of microparticles. FACS is used heavily in the
fields of molecular and cell biology2 to sort single particles (typically cells) based on opti-
cal characteristics such as scattering or fluorescence [91]. Commercial FACS instruments
can typically handle objects ranging from ∼500 nm to > 100 µm in size, and are ca-
pable of particle throughput in excess of 10,000 particles/s [91], with newer instruments
2For reference, the number of papers in the NCBI Pubmed database containing the phrases
“flourescence-activated cell sorting” or “flow cytometer” has exceeded 10,000 every year from 2010 to
2015.
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Figure 3.1: FACS scheme
exceeding 50,000 particles/s. Here we use FACS to analyze and sort mixtures of shaped
polystyrene microparticles using single-particle elastic optical scattering measurements.
With no special sample preparation or labeling required, we achieve high separation
purity, throughput, and yield for a variety of particle morphologies.
3.2 Background and Theoretical Framework
3.2.1 FACS and Flow Cytometry
FACS is a flow-based single-particle analysis and sorting tool. There are three major
elements to any FACS system: fluidic handling, optical interrogation, and particle sort-
ing. A schematic of a FACS instrument is shown in Figure 3.1. A suspension containing
cells or particles to be analyzed is flowed into the instrument. The sample stream is
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coaxially injected through a flow nozzle into a saline buffer sheath flow that serves to
hydrodynamically focus particles to a well-defined flow region in the core of the sheath
flow. This hydrodynamic focusing process also ensures that particles flow through the
instrument in single-file, enabling single particles to be interrogated one at a time and
precisely manipulated downstream. The focused particles are subsequently illuminated
by one or more lasers for fluorescence excitation as well as elastic scattering measure-
ments. Scattered light is collected for measurement in two directions: at small (0±5 deg)
angular deviations from the laser’s direction of incidence (“forward scatter” or FSC) as
well as perpendicular to the incident light (90±5 deg) (“side scatter” or SSC). Scattered
light is collected and focused to detectors (FSC light is measured with a photodiode, while
SSC and fluorescence are measured with PMTs). After optical interrogation, particles
pass through a droplet nozzle that is excited at ultrasonic frequencies by a piezoelectric
vibrator. Just as these droplets are broken off the main sample stream into air, a charging
collar applies a net negative or positive charge (or no charge) to each droplet depending
on the desired deflection. The ejected droplets then pass through a fixed electric field
between two charged deflection plates; the direction and amplitude of their deflection is
controlled by the polarity and amount of charge they receive from the charging collar
at the droplet nozzle. Finally, the droplets are collected in tubes placed at appropriate
angles beneath the deflection plates to collect the deflected droplets.
Analysis in FACS instruments is performed on the basis of the various scattering
and fluorescence measurements that have been collected for each particle. To facili-
tate population-level visualization and sorting, FACS data are typically presented as 1-
dimensional histograms (for examining a single measurement parameter for a collection
of particles) or as correlated 2-dimensional scatter plots (for examining two measure-
ment parameters simultaneously), where each point represents a single particle. Sorting
is achieved by defining “gates,” one-dimensional intervals or two-dimensional regions of
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interest on these histograms or scatter plots. Detected particles, or “events,” can be
deflected to specific collection tubes based on whether or not they reside in a given gate.
By performing Boolean gating, wherein gates are combined or assembled into hierarchies,
particles can be classified and sorted based on more than just two parameters.
3.2.2 Elastic optical scattering in FACS
While FACS is most often thought of as a tool for measuring fluorescence (i.e., inelas-
tic optical scattering), it is also used to measure the elastic optical scattering properties of
cells and microparticles. Fundamentally, scattering describes the interaction of incident
light with dipoles in matter; elastic optical scattering involves light-matter interactions in
which the energy (wavelength) of the incident and scattered light is the same. Scattering
behavior —described by the angular intensity distribution and polarization of scattered
light relative to the incident light —is strongly dependent on the wavelength and polar-
ization of the incident light, as well as the intrinsic (refractive index) and extrinsic (size,
shape) properties of the scatterer itself. In flow cytometry, the intensity of scattered light
at small angles relative to the direction of incidence (forward scatter) is often used to
gain insight into the size and refractive index of the interrogated object, while large-angle
scattering (side scattering) provides additional information about the object’s granularity
or surface roughness.
Elastic scattering in flow cytometers has been rigorously characterized, both exper-
imentally and theoretically using electromagnetic scattering theory. For instance, for
polystyrene spheres, the strong dependence of FSC and SSC amplitude on particle size
can be predicted using Mie theory (described below) [92]. Interestingly, the specific
optical geometry of the FACS instrument has an important impact on scattering mea-
surements. For example, the angular width of the forward scatter obscuration bar, which
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blocks unscattered incident illumination at ∼ 0◦ from swamping the FSC detector, was
found to affect the quantitative relationship between particle size and FSC intensity [92].
The role of incident beam geometry has also been explored [93]. The scattering proper-
ties of biological particles across a wide range of sizes have been rigorously characterized
using FACS, ranging from cells on the order of 10s of microns [94–96] to sub-micron
protein aggregates [97] and vesicles [98–100]. A good review of single-cell scattering
analysis, including FACS and other methods, is provided by Kinnunen et al. [101]. Of
note, the same fundamental phenomenon of elastic optical scattering is frequently used
in synthetic particle characterization, whether in ensemble approaches such as dynamic
light scattering or in single particle analyzers such as aerosol monitors [88–90].
In addition to using FACS to measure the amplitude of elastically scattered light,
useful information about particle morphology may also be obtained by analyzing the
temporal shape of the scattering signal pulse at the photodetector [102], which is gener-
ated as the particle passes through the interrogation beam. Sharpless et al. found that
the pulse width of both the fluorescence signal [103] and the FSC signal [104] for spherical
synthetic microparticles are strongly correlated with particle size. Leary and coworkers
found a similar relationship between FSC pulse width and microsphere diameter [105].
Interestingly, the relationship between size and pulse shape differs significantly for FSC
in comparison to SSC [102]. Pulse-width analysis has since been used extensively for size
discrimination for a variety of biological targets such as endosomes [106, 107], immune
cells [108], and algae [109].
Based on the fact that scattering can be measured at multiple angles (FSC and SSC)
and analyzed using multiple parameters (scattering amplitude and pulse width), combi-
natorial analysis can enable more effective particle discrimination than the use of single
parameters alone [110]. Terstappen et al. showed that by using various combinations of
scattering parameters, the four most clinically-relevant distinct subtypes of white blood
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cells can be separated from each other out of a white blood cell mixture [111,112]. Recent
work by Tzur et al. found that gates based on combinations of scattering parameters
(such as scattering amplitude and pulse width) are more effective for size-based discrim-
ination than either parameter alone, for a wide variety of cell types [113].
3.2.3 Optical scattering for analysis and sorting of nonspherical
particles
As described above, the relationship between scattering measurements and particle
size has been extensively characterized; however, there is comparably little research re-
garding the use of scattering in FACS to characterize particle shape independent of size,
even though the scattering behavior of both nonspherical cells [114] and nonspherical syn-
thetic microparticles [115] is known to be orientation-depedent. In a patent application
regarding a FACS-basd pulse-width analyzer, Leary et al. noted that pulse width mea-
surements vary for identical nonspherical particles depending on their orientation when
entering the interrogation beam [116]. The most common use of FACS for shape-based
particle discrimination is blood typing, where disk-shaped erythrocytes can be separated
from more spherical leukocytes. Early work by Salzman and coworkers showed that the
optical scattering of disk-shaped red-blood cells takes on a unique distribution based on
the range of potential orientations that the cells can take when being interrogated [117].
3.2.4 Simulating elastic optical scattering
While elastic optical scattering can be fully described across all length scales by solv-
ing Maxwell’s equations, this is analytically and computationally impractical for all but
the simplest scatterer geometries. It is therefore useful to consider a number of approxi-
mations that apply in limiting size regimes described by the characteristic scattering size
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parameter x = 2pia
λ
, where a is the effective radius of the scatterer and λ is the wavelength
of the incident radiation. For particles significantly smaller than the incident wavelength
(Rayleigh scattering, where x 1), the particle effectively acts as a single dipole, scatter-
ing light equally in all directions independent of shape but dependent on size, refractive
index, and incident wavelength. For scatterers much larger than the illuminating wave-
length (x 1), the classical macroscopic descriptions provided by geometric optics, such
as reflection and refraction, are sufficiently descriptive. For microparticle scattering, we
are interested in an intermediate regime where the scatterer has a size similar to the
incident wavelength; unfortunately, calculating such scattering behavior is more difficult
than the large and small extremes described above due to the lack of simple approxima-
tions. Nevertheless, a number of approaches to obtaining approximate or exact solutions
to Maxwell’s equations may be used for particles in this size range. Mie theory in partic-
ular is a powerful tool, providing an exact solution to Maxwell’s equations for an incident
electromagnetic plane wave interacting with homogenous spherical scatterers [118].
While electromagnetic scattering of homogeneous spheres is a solved (and computa-
tionally tractable) problem using Mie theory, scattering of nonspherical particles is more
difficult to simulate. Geometric approximations based on Mie theory have been explored
for prolate and oblate spheroids [119]. Alternatively, the T-matrix method provides an
exact solution for nonspherical scatterers [120]. T-matrix calculations have been used to
predict scattering for spheroids [121], ellipsoids [122], and cylinders [123]. Spheroid-based
simulations have been found to predict experimental scattering behavior of particles of
arbitrary shape [124].
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3.3 Results and Discussion
3.3.1 Optical scattering is dependent on particle shape, size,
and orientation
We characterized microparticles in FACS using optical scattering measurements, cap-
tured both in the direction of incidence (FSC) and orthogonal to the direction of incidence
(SSC). The intensity of scattered light in these directions is converted to a voltage by
either a photodiode (for FSC) or PMT (for SSC), giving a characteristic voltage pulse
for each particle as it passes through the interrogation beam. The FACS instrument dig-
itizes this pulse and records the peak height (H) as well as the integrated pulse area (A).
The pulse width (W) is then calculated and reported as the ratio of peak area to height.
Since pulse width is calculated from the other two parameters, there are effectively only
two “independent” pulse shape parameters; the pulse shape information provided by the
instrument is fully contained in any pair of the three available parameters H, A, and
W. For simplicity, we use pulse height and pulse width only. Therefore, since there are
two scattering detectors, each particle’s measurement has four independent parameters:
pulse height and width at the forward detector (FSC-H and FSC-W), and pulse height
and width at the orthogonal detector (SSC-H and SSC-W). Pulse height is closely related
to the amplitude of the scattered light, while pulse width is a more complex function of
both the particle’s residence time in the interrogation beam as well as the shape of the
pulse during interrogation.
We measured FSC and SSC for a variety of polymer microparticles with different
morphologies. As a model system, we used microparticles formed by stretching an initial
suspension of monodisperse polystyrene microspheres (6 µm diameter) in the manner de-
scribed by Champion, et al. [62]. Specifically, we examined spheres and ellipsoids (aspect
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(a) SEM images of stretched polystyrene ellipsoids with aspect
ratios of (left to right) 1.0, 2.0, 3.0, and 4.5.
(b) Scattering profiles for microparticles with varying aspect ratios.
Figure 3.2: Shape dependence of scattering profiles for ellipsoids
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Figure 3.3: Scattering profiles of AR 4.5 ellipsoids arise from particle orientation, not
sample heterogeneity. (top) Particles falling in gates P1 (red) and P2 (blue) were
separately collected and re-analyzed in the instrument (bottom), each yielding the
full scattering distribution of the original suspension.
ratios ranging from 1.1 to 4.5). Notably, all microparticles we examined had identical
volumes and densities, differing only in terms of their shape. Nevertheless, we found
that each particle morphology, when analyzed by scattering measurements in FACS, ex-
hibited a distinct range of scattering parameters (FSC-H, FSC-W, SSC-H, and SSC-W).
Two-dimensional correlated scatter plots show unique “scattering profiles” arising from
particles of different morphologies. Spheres exhibit a relatively narrow distribution for all
four parameters, while increasingly eccentric particles yield a significantly wider range of
FSC-H, FSC-W, SSC-H, and SSC-W values. The complexity of these correlated scatter
plots increases for increasingly nonspherical particles.
We next sought to determine whether scattering profiles are due to sample hetero-
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geneity or are intrinsic to particle morphology, arising from the ensemble of random
orientations available to the particles as they pass through the optical interrogation re-
gion. Due to the fully developed laminar (Poiseuille) flow in the sample stream, there is
a parabolic velocity distribution across the cross section of the stream, such that fluid in
the center of the stream flows faster than fluid at the channel walls. Consequently, par-
ticles passing through the sample stream experience a net torque and undergo rotation,
leading to a full range of possible orientations for any particle entering the interrogation
beam [125]. Because the angular distribution of scattering intensities is highly depen-
dent on particle orientation relative to incident radiation [119], this leads to a range of
potential FSC and SSC intensities for any given particle, depending on its orientation.
To verify this, we defined sorting gates P1 and P2 on a 2-D scatter plot of FSC-H vs
SSC-W for a relatively monodisperse suspension of AR 4.5 ellipsoids. These gates en-
capsulated two distinct population density peaks along the SSC-H dimension. Particles
from each gate were collected and separately re-analyzed in the FACS instrument. A bi-
modal scattering profile nearly identical to that of the original unsorted suspension was
observed for the particles obtained from both gates, strongly suggesting that the scatter-
ing distribution arises primarily from random particle orientations and not from sample
heterogeneity. 3 Similar results were obtained for a suspension of stretched discs showing
a trimodal population density distribution (data not shown); in this case, a three-way
sort was performed and the sorted suspensions were re-analyzed, each yielding the full
scattering distribution independently. Similar behavior has previously been reported for
red blood cells, where the disc-like geometry results in a range of FSC and SSC intensities
based on cell orientation [126,127]; cells collected from non-overlapping gates yielded the
same full distribution of scattering parameters when re-measured in the instrument.
3Notably, there is a difference in the relative population percentages for the P1 and P2 gates in the
two sorted samples, likely due to some polydispersity in the starting suspension.
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(a) Histograms of side-scatter intensity (integrated intensity
over a solid angle spanning 83◦ to 97◦ in both the azimuth and
zenith angles in the instrument coordinate system, see [128] for
geometry details) for randomly oriented particles of varying as-
pect ratio, as simulated using the T-matrix method.
(b) Measured histograms of SSC-H for particles of varying as-
pect ratio.
Figure 3.4: Scattering simulations of side-scatter intensity distributions match the
relationship between differently-shaped particles observed in experimental scattering
measurements, further confirming that the observed distribution of scattering param-
eters arises due to random particle orientations. The discrepancy between simulated
and measured scattering for spherical particles is likely due to slight polydispersity in
the spherical particle suspension, resulting in a broader distribution.
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We further sought to verify that the scattering profile arises from random scatterer
orientations by performing numerical electromagnetic scattering simulations. Specifically,
we used the T-matrix method [128, 129] to simulate scattering of spheres and ellipsoids
with AR 1.5 and 2.5. These simulations calculate the angular dependence of the scattered
light intensity for a variety of particle orientations relative to the direction of incident
radiation. Using this approach, we show that the distribution of orthogonal scattering
amplitudes (SSC-H) is predicted well by scattering at random orientations. These sim-
ulations match both the experimentally-observed distributions of values observed for all
three particle types, as well as their relative values from shape-to-shape. Notably, this
simulation does not capture the nonuniform incident beam geometry, which has a Gaus-
sian intensity profile [91] and is focused to a height of 9 mum, smaller than the longest
dimension of the AR 2.5 ellipsoids. This may explain the lack of measured high-intensity
values for AR 2.5 compared with the simulated results. Due to convergence limitations
of the specific T-matrix algorithm employed here, only aspect ratios up to 2.5 could be
explored for particles of this volume using 488 nm illumination [130].
3.3.2 Defining gates to separate particles
We next attempted to sort a heterogeneous mixture of ellipsoidal particles (Figure
3.5a) based on scattering measurements. To do this, we sought to define minimally
overlapping sort gates on a 2D correlated scatter plot of scattering parameters. We
therefore decided to define gates on a plot of FSC-H vs. SSC-W, because the four
different types of ellipsoids exhibited distinct (though overlapping) scattering profiles
for this parameter pair. The scatter plot for the 4-way particle mixture is shown in
Figure 3.5b. Sort gates were defined manually using the following procedure. First,
population density plots of each particle type were examined to determine the highest-
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density regions. Initial “high-yield” gates for each particle type were created around these
population peaks. For each particle type, we then applied the high-yield gate to scatter
plots of the three other particle types to see how many non-target particles would be
included (e.g., how many particles of AR 2.0, 3.0, or 4.5 would be included in the initial
high-yield gate for AR 1.0). The high-yield gate was then manually adjusted to include
the highest-density regions of the target particle type, while avoiding the highest-density
regions of the non-target particle types. In this way, high-purity gates for each particle
type could be defined (Figure 3.5c).
The results of this 4-way sort based on 2D gates are shown in Figure 3.6a. Sorted
particle mixtures were recovered from the instrument and analyzed via optical microscopy
to determine the sort purity (details in Section 3.5.4); purity values were renormalized to
reflect a hypothetical 0.25:0.25:0.25:0.25 distribution of particle types as the sorter input.
Although all sort gates resulted in purities exceeding 75%, only the gates for AR 1.0 and
AR 4.5 particles resulted in purities above 95%. The lower purity achieved by the AR
2.0 and AR 3.0 gates can be attributed to a significant degree of overlap between these
populations on the plot of SSC-W vs. FSC-H (Figure 3.6b). Moreover, there is significant
overlap between the scatter plots for AR 3.0 and AR 4.5 particles, further worsening the
purity of the AR 3.0 gate. Notably, the AR 1.0 and AR 4.5 gates both result in relatively
high purities because their respective areas of highest population density are far from the
population peaks of the other particle types.
3.3.3 Sorting with higher-dimensional gates
While sorting based on 2-D gates is possible, the highest purity attainable is lim-
ited by overlap between closely-related particle types. However, there are a total of 4
independent parameters available for sorting. The correlation between these scattering
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(a) Heterogeneous particle mixture for sorting, con-
taining microparticles with aspect ratio 1.0, 2.0, 3.0,
and 4.5
(b) Scattering profile for heteroge-
neous mixture
(c) Sorting gates for each particle type
Figure 3.5: Two-dimensional gate design for ellipsoid sorting.
53
Shape-based Separation of Synthetic Microparticles with FACS Chapter 3
(a) Purity for each particle type after performing the
2-D sort
(b) Closely related particle types have sig-
nificant overlap in their 2-D scatter profiles
Figure 3.6: Sorting of ellipsoids based on 2-D gates
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parameters for various particle types can thus be considered in a higher-dimensional
space, as shown for example in the 3-D correlated scatter plots of FSC-W vs. FSC-H
vs. SSC-H (Figure 3.7). Such higher-dimensional visualization reveals that populations
which appear to significantly overlap on any given 2-D parameter space may actually be
possible to separate in the higher-dimensional scattering space.
However, sorting particles based on gates defined in higher-dimensional space (3-
D or 4-D) presents two important technical and practical challenges. First, we must
determine a method for rigorously defining particle-specific regions in higher-dimensional
scattering space that do not overlap each other. While visual inspection of the plots
in Figure 3.7 suggest that such regions exist, defining and optimizing them is not a
straightforward task. While a number of statistical tools are available for defining clusters
in higher-dimensional FACS data [131–142], these are primarily designed to discover and
distinguish unknown cell populations. Our problem is the inverse: we already know
the unique scattering profiles for each particle type, but now want to determine the
optimal higher-dimensional region for maximizing both yield and purity. The second key
challenge is both practical and technical: the higher-dimensional gates, once discovered
and defined, must then be translated for sorting with the FACS instrument software.
Unfortunately, commercial FACS instruments are only capable of sorting based on gates
drawn on 1-D histograms or 2-D correlated scatter plots; no software tool exists for
sorting directly based on 3-D, 4-D, or higher-dimensional gates.
To overcome these problems and sort using 4-D gates, we first exploited the fact that
a convex region in higher-dimensional space can be reconstructed from its projections
onto lower-dimensional spaces. For each particle type, we defined a 4-D gate by creating
2-D gates on multiple 2-D parameter spaces (with 6 different 2-D spaces available based
on pairwise combinations of FSC-H, FSC-W, SSC-H, and SSC-W). These 2-D gates are
manually selected for yield and purity following a procedure similar to that described in
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(a) (b)
(c) (d)
Figure 3.7: 3D visualization of scattering profiles for a four-component particle mixture
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Section 3.3.2. The intersection of this set of 2-D gates then defines a particular region
in 4-D space; and, because FACS software allows sorting based on Boolean combinations
of 2-D gates, we can perform a sort based on this 4-D region using a logical “AND”
combination of its constitutive 2-D projections. Therefore, this projection-reconstruction
approach enables us to begin solving the two problems described above, by (i) facilitating
the definition of a 4-D sorting region for each particle type and (ii) providing a simple
means of translating that region to the FACS software for actual sorting.
However, while this projection-reconstruction approach can recreate simple convex
regions in 4-D space, it is unable to capture more complicated geometric features such
as concave regions, gaps, and holes. Practically, this limits the maximal purity attain-
able using gates developed with the projection-reconstruction approach, due to the high
degree of overlap of different particle types’ scattering profiles. To achieve higher purity,
we need to define more complex 4-D regions in a manner that is still compatible with
the constraints of the FACS software. We can achieve this higher geometric complexity
by “rasterizing” the 4-D regions. This is achieved by defining 1-D slices (in the form
of interval gates on a histogram plot) along one parameter axis, and creating multiple
2-D gates within the subpopulation defined by that slice using combinations of the other
three parameters (e.g., define a slice on the histogram of SSC-H, then create 2-D gates
using combinations of FSC-H, FSC-W, and SSC-W). This approach allows complex 4-D
geometries to be built up slice by slice. Moreover, this approach is compatible with the
FACS sorting software, which allows sorting based not only on Boolean gate combina-
tions, but also on nested sub-gates (e.g., gates defined as subsets of populations defined
by other gates). In this manner, each 1-D slice is a separate subpopulation of the total
parent population; sets of intersecting 2-D gates are then applied to these subpopulations
independently.
Using the combined rasterization and projection-reconstruction method, we per-
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Figure 3.8: Results of sorting ellipsoids based on 4-D gates
formed a four-way sort based on 4-D gates. The specific gates used for each particle type
are shown in Appendix B. Optimal gate combinations to achieve maximal purity were
selected manually. We note that these sort gates do not necessarily use all possible com-
binations of scattering parameters; rather, an optimal combination of lower-dimensional
gates was chosen that maximized purity while maintaining a reasonable yield. The results
of the four-way 4-d sort are shown in Figure 3.8, compared side-by-side with the results
of the 2-D sort. The 4-D sort resulted in sort purities above 95% for each particle type,
with dramatic improvements for the AR 2.0 and AR 3.0 gates. These results demon-
strate that sorting based on 4-D gates can overcome the purity limitations of 2-D sorting,
by enabling separation of closely related particle morphologies in a higher dimensional
scattering space.
3.3.4 Morphology-based enrichment from polydisperse suspen-
sions: diblock copolymer “micro-footballs”
To demonstrate the utility and generality of our approach, we applied FACS to sort
a “real-world” polydisperse mixture of nonspherical microparticles. Football-shaped
58
Shape-based Separation of Synthetic Microparticles with FACS Chapter 3
poly(styrene-b-2-vinylpyridine) (PS-b-P2VP) diblock copolymer microparticles can be
synthesized with alternating stacked lamellar domains of PS and P2VP, causing them
to act as Bragg reflectors. These “micro-football” particles have applications in stimuli-
responsive optics, wherein pH can be used to tune the relative spacing of the lamellar
Bragg domains and thus the particle color, while particle-to-particle arrangement can
be used to tune overall reflectance. Such controllable optical properties, however, de-
pends on well-defined particle morphology. Unfortunately, when synthesized through
shear-induced emulsification, the resultant microparticle mixture is highly polydisperse
(Figure 3.9a).
We used FACS to sort this polydisperse micro-football mixture. Unlike the stretched
polystyrene spheroids used before, this mixture does not have well-defined subpopula-
tions; rather, it contains a continuum of particle sizes and shapes. Consequently, the
measured scattering profile of the polydisperse mixture shows a wide range of FSC-A
and SSC-A values (Figure 3.9b). As a preliminary test, we sorted based on a number of
2-D gates in different regions of the correlated scatter plot (colored areas in Figure 3.9c).
Sorted particles were recovered and analyzed via optical microscopy as before. Each gate
resulted in a unique distribution of particle sizes as characterized by the particles’ major
axis length (Figure 3.10). For example, the high-FSC gate (gate 1, blue) contained far
more particles with major axis lengths above 4 µm than the starting mixture or any of
the other gates. Interestingly, although gates 2 and 3 (orange and magenta) have similar
FSC-A values and differ only along the SSC-A axis, their resulting size distributions are
appreciably different. These results show that FACS can be used to enrich subpopula-
tions of a polydisperse particle mixture based on morphology, even when the scattering
profiles of the individual subpopulations are not known ahead of time.
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(a) SEM micrograph of polydisperse micro-footballs
(b) 2-D scattering profile for polydis-
perse mixture of micro-footballs
(c) Sorting gates (colored regions)
Figure 3.9: Sorting gates for diblock copolymer micro-footballs
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Figure 3.10: Sorting micro-footballs based on scattering results in selective enrichment
for particles of various sizes in each gate.
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3.3.5 Discussion
In this work, we have demonstrated the first use of a commercial FACS system to
sort synthetic microparticles based on shape. Using only elastic optical scattering mea-
surements captured at two angles, we showed the ability to sort multiple varieties of
particle morphologies out of heterogeneous suspensions. Furthermore, by utilizing 3- and
4-dimensional gating strategies, we achieved high purity separation for closely related
particle morphologies.
Although these preliminary sort results are promising, there are a number of areas
of improvement that future works should address. First, for this work, we have focused
primarily on maximizing purity; however, many applications of particle synthesis would
also require high yield in order to obtain usable quantities of the desired particle mor-
phology. Future gate design procedures, similar to those described above, could take into
account the balance between yield and purity, enabling the selection of higher-yield or
higher-purity gates depending on the application. The actual instrument yield should
also be measured and compared to the predicted gate yield. Second, our existing gating
strategy depends ultimately on manual, user-defined gates. While this is sufficient to
achieve the high purities obtained in this work, it is time-intensive and ultimately too
subjective to be useful as a general approach. Future algorithms could be developed to
automate gate selection in either a deterministic fashion, where high-purity and high-
yield regions of the 4-dimensional scattering space are selected according to pre-defined
design rules, or in a probabilistic fashion, where psuedorandomly generated “seed” gates
are tested and gradually evolved to maximize purity and/or yield. Third, further testing
with additional morphology types, beyond ellipsoids, should be performed. Preliminary
results with stretched discs (data not shown) suggest that this approach is generalizable
to multiple particle geometries.
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To gain insight into the fundamental nature of FACS-based scattering measurements,
we performed simple scattering simulations to verify the orientation dependence of our
measured scattering profiles. However, these simulations made a number of simplifying
assumptions that should be either validated or corrected in the future. For instance, the
simulations assume that our particles are perfect prolate spheroids (where the lengths of
the two minor axes are equal), but they are actually irregular ellipsoids with significantly
varying minor axes. In addition, the simulation does not take into account the FACS
laser’s nonuniform Gaussian intensity profile [91]. Future simulations should also more
carefully leverage scatterer symmetry to reduce the necessary range of orientations to
test and therefore speed up simulation time [93]. In addition, it may be possible to
directly simulate arbitrary shapes [143, 144], further increasing the utility of scattering
simulations for optimizing FACS-based particle sorting.
Even if these improvements are made, however, there are a number of limitations
to this method that are potentially intrinsic to the FACS instrument. First, scattering
and pulse width measurements are highly dependent on the specific optical geometry
of the FACS instrument being used [110], potentially leading to unpredictable results
for the same particle system when analyzed on different models of cytometer. However,
we note that we developed our method on one of the most common FACS systems in
use in the U.S. (the BD FACSAria II). In addition, the fluidic setup of the cytometer
will have an important effect on the ensemble of microparticle orientations; for instance,
stream-in-air FACS systems will tend to align oblong microparticles in the direction
of flow, potentially resulting in different scattering profiles for the same microparticles
from cytometer to cytometer. We also have demonstrated our system using polystyrene
particles, which have a large refractive index mismatch with water and therefore scatter
strongly. Materials with refractive indices closer to that of water may not provide as
distinct of a scattering profile. Finally, we note that this method may not be suitable
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for microparticles that are only stable in non-aqueous solvents, since most commercial
FACS systems are only designed for use with water.
3.4 Conclusion
Shape-based microparticle sorting in FACS is a promising and potentially general
approach to enriching designer microparticles based on morphology. Commercial FACS
systems are becoming increasingly ubiquitous in both academic and industrial research
settings, making our method accessible to a wide range of researchers. In the future,
by exploiting other optical tools built into FACS instruments —such as the ability to
measure particle autofluorescence at a variety of excitation wavelengths —FACS-based
sorting could be used to enrich microparticles based on other material properties in
addition to morphology. By leveraging the high performance (throughput and precision)
of commercial FACS instruments, shape-based particle sorting with FACS could become
a standard tool for laboratory-scale microparticle enrichment.
3.5 Experimental Methods
3.5.1 Microparticle synthesis and characterization
Microparticles were fabricated by the process described in [63]. Briefly, monodisperse
spherical polystyrene (PS) particles (diameter of 6 µm) were suspended in an aqueous
solution of polyvinyl alcohol (PVA) which was subsequently spread and dried into a
sheet. The sphere-embedded sheet was then heated to 120 ◦C and stretched to achieve
the desired particle shape, followed by cooling and washing to remove any PVA residue.
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3.5.2 FACS instrumentation and operating procedure
All experiments were performed on a BD FacsAria II cell sorter. Particles were
suspended in DI water and were sonicated for 5 min, vortexed, and filtered through
a 35 µm filter prior to analysis. Unless otherwise noted, samples were processed at a
cytometer flow rate setting of “1.0,” corresponding to a flow rate of approximately 16
µl/min. Particles were sorted into 1.5 ml Eppendorf tubes containing 100 µl of DI water.
3.5.3 Scattering simulation validation
Angular scattering distributions for polystyrene ellipsoids were simulated in Python
using a specific implementation of the T-matrix method, described by Mishchenko et
al. [128] and released in Python by Leinonen et al. [129]. To validate this T-matrix
algorithm, scattering from homogeneous spheres was simulated using both the T-matrix
method and a well-characterized program based on Mie theory developed by Matzler et
al. [145]. Simulations from both algorithms were performed for spheres of identical size
and refractive index, resulting in exact overlap of the scattering distributions calculated
by the two methods.
3.5.4 Microscopy analysis procedure for sorter results
Sorted particle samples were centrifuged at 13.7 krcf for 2 minutes to concentrate all
particles at the bottom of the tube, and the supernatant was removed and saved so that
only 40 µl of concentrated particle solution remained. The concentrated suspensions
were then vortexed and 5 µl samples were pipetted onto a microscope coverslip placed on
the imaging stage of an Olympus IX-73 inverted microscope. Particles were allowed to
settle via gravity. Microscope images were captured across the entire deposited sample
drop by scanning across the drop’s width and height. Unless otherwise noted, all images
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were captured in brightfield at a magnification of 40x using a Phantom v211 camera.
Unsorted “input” particle suspensions were not concentrated prior to imaging.
Identification of particles in sorted samples containing highly distinguishable particle
types (e.g., spheres vs. ellipsoids or ellipsoids vs. discs) was performed manually. For
samples containing particle types that were difficult to reliably distinguish manually (e.g.,
ellipsoids with aspect ratio 2.5 vs 3.5), images were analyzed by a feature-identification
program in MATLAB as follows. First, captured images were manually segmented in
MATLAB to identify individual particles. The segmented regions were then analyzed
with an ellipse-detection program in MATLAB that performs Canny edge detection and
subsequently uses a Hough transform to calculate the best-fit ellipse for each edge in the
image, using parameters for major axis length, minor axis length, center X-Y coordinates,
and rotation angle4. Fitted ellipses were manually verified for each particle through visual
inspection. The major axis of the fitted ellipse was found to be the most reliable particle
identifier and was used to classify detected particles by their aspect ratio.
4Available on Mathworks Exchange at http://www.mathworks.com/matlabcentral/fileexchange/33970-
ellipse-detection-using-1d-hough-transform, based on [146].
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Chapter 4
High-Speed Image-Based Sorting of
Cells and Microparticles
4.1 Introduction
1 Flow cytometry and cell sorting have become irreplaceable tools for cell biology
and bioengineering, enabling researchers to study large cell populations with single-cell
resolution at high throughput. The current “gold standard” for cytometry is fluorescence-
activated cell sorting (FACS), wherein cells are labeled with fluorescent stains or fluorophore-
labeled antibodies and are subsequently analyzed based on their fluorescence signatures.
Modern FACS instruments can achieve very high sort throughput (approaching 50,000
cells/s for state-of-the-art systems) and are capable of analyzing multiple fluorescence
channels simultaneously, enabling serial sorting and enrichment of target cells based on a
wide variety of phenotypic criteria. However, this high throughput comes at the expense
of spatial resolution: FACS is based only on single point measurements of whole-cell
1At the date of compiling this thesis, March 17, 2016, this work is still in progress. The contents are
thus presented as preliminary results.
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fluorescence or scattering intensity.2 Because of this lack of spatial resolution, FACS is
incapable of sorting cells based on complex morphologies or internal cellular features,
such as the spatial distribution of organelles or fluorescently-tagged proteins. Such 2-
D information is necessary for studying cell cycle progression [147], protein aggregation
disorders such as amyloidosis [148], nuclear translocation [149], and endosomal traffick-
ing [150], to name a few. Two-dimensional spatial data is capable of conveying far more
biologically useful phenotypic information than whole-cell fluorescence alone [151], but
to date there is no system capable of sorting at FACS-like throughput based on two-
dimensional microscopy.
The field of imaging flow cytometry has partially solved this problem by combining
the rich spatial information of traditional 2-D microscopy with the high throughput of
flow cytometry [152]. Unlike FACS, imaging flow cytometers capture full 2-D images of
single cells in flow using a CCD or CMOS detector, providing multi-channel fluorescence
images in addition to brightfield, darkfield, and (in some instruments) phase contrast
images. Advances in high-speed CCD and CMOS technology have made it possible for
commercial imaging flow cytometers to reach imaging throughputs approaching 5,000
cells/s at the time of writing this dissertation [149, 152, 153]. However, to date none
of these systems are capable of sorting cells based on images. This is because imaging
flow cytometers cannot perform real-time image analysis, instead depending on post-
processing and off-line analysis after cell images have already been acquired. Such an
approach is understandable, since extracting biologically relevant features from 2-D im-
ages is a computationally expensive task. Nevertheless, image-based cell sorting would
require not only high-throughput image acquisition, but also real-time image analysis to
classify cells for sorting based on image features.
2As discussed in the previous chapter, scattering measurements and fluorescence pulse width analysis
do provide some basic spatial information about cell shape and size.
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Here we present a system capable of high-throughput image-based sorting of cells
and microparticles. Our SuperFACS3 system combines high-speed CMOS imaging with
optical microscopy and real-time image analysis to perform active image-based sorting on
a microfluidic chip. To achieve this, we developed a microfluidic sorting platform, a real-
time image acquisition interface, and real-time analysis algorithms for object detection,
tracking, and feature extraction. We demonstrate sorting of synthetic microparticles
based on size and shape, and show preliminary results for internal feature-based sorting
of induced pluripotent stem cell-derived retinal pigment epithelium (iPSC-RPE) cells.
4.2 Background and Theoretical Framework
4.2.1 Imaging flow cytometers and image-based sorters
While FACS-based sorting is widespread, no commercial image-based sorters are avail-
able. A small number of image-based sorters have recently been reported in the litera-
ture, capable of sorting synthetic microparticles [154], bacteria culture in droplets [155],
murine macrophages [156], and human embryonic stem cells [157] all based on simple
image features like size, granularity, or single channel fluorescence intensity. Crucially,
these systems are all limited to throughputs < 100 cells/s, many orders of magnitude
lower than those reached by FACS systems. This is primarily due to their slow analysis
algorithms (each taking on the order of ∼10 ms/cell). An imaging flow cytometer capable
of real-time image analysis, without sorting, was reported to reach higher imaging and
analysis throughputs of close to 500 cells/s, with an analysis time per frame of only 250
µs [158]. This fast analysis time was achieved through the use of highly optimized C++
code using the OpenCV image analysis library, implemented on a standard PC with a
3Yes, really.
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six-core central processing unit.
4.2.2 Pressure-driven flow in microfluidic channels
Designing microfluidic flow channels for microparticle and cell manipulation requires
an understanding of the physics of pressure-driven flow. For the simple case of pressure-
driven laminar flow of an incompressible Newtonian fluid in a rigid channel, the important
physical variables describing the system are pressure, hydraulic resistance, and volumet-
ric flow rate. These quantities are related by the Hagen-Poiseuille equation for long
cylindrical flow channel geometries:
∆P =
128µLQ
pid4
(4.1)
where ∆P is the pressure drop, µ is the dynamic viscosity, L is the length of the channel,
Q is the volumetric flow rate, and d is the diameter of the channel. By defining the
hydraulic resistance RH = 128µL/pid
4, the Hagen-Poiseuille equation takes the form
∆P = QRH . (4.2)
This is directly analogous to Ohm’s law for voltage drop across a resistor, ∆V = IR,
where pressure P , flow rate Q, and hydraulic resistance RH are analogous to voltage
V , current I, and electrical resistance R, respectively. Similar analogies apply for other
well-known rules describing electrical circuits. For instance, Kirchoff’s voltage law and
Kirchoff’s current law can be recreated by considering mass and energy conservation in
fluidic systems, leading to directly analogous rules describing flow and pressure drops in
multi-channel, multi-node microfluidic systems. This leads to familiar solutions for total
hydraulic resistance in networks of fluidic channels connected in series or in parallel.
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Other insights from circuit theory can be applied using the same basic mathematics,
such as the design of constant-pressure and constant-flow sources, as well as pressure and
flow rate dividers. A good overview is provided in [159].
Due to the practical constraints of microfluidic channel fabrication, many microfluidic
systems utilize rectangular channel geometries instead of circular cross-sections. While
Equation 4.1 applies only to cylindrical channels, a general hydraulic resistance RH can be
defined such that Equation 4.2 applies to arbitrary channel geometries. For rectangular
channels of height h and width w (with w > h), the hydraulic resistance is given exactly
by [160]
RH,rec =
12µL
h4
(
w
h
−
(
192
pi5
∑∞
n=1
1
(2n−1)5 tanh
(
(2n−1)piw
2h
))) . (4.3)
Thus, RH increases linearly with channel length L and is inversely proportional to the
fourth power of h, with an additional geometric factor dependent on channel aspect
ratio.
4.2.3 Dielectrophoresis
To enable high-speed sorting of cells and microparticles, we require a rapidly switch-
able, nondestructive actuation technique. Hydraulic switching using valves is gentle, but
limited in throughput due to compliance in the fluidic system. Electrophoresis, while
rapidly switchable and popular for macromolecule separation, requires the object being
manipulated to have a net charge; in addition, it requires the use of strong DC fields,
which can interfere with cell function (and even cause cell death) and can lead to un-
wanted bubble generation in the device due to electrolytic water splitting. An extensive
review of microfluidic particle manipulation approaches is provided in [161]. Dielec-
trophoresis (DEP), on the other hand, exploits the force experienced by a dielectric
object suspended in a medium of differing complex permittivity, all under the influence
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of a spatially nonuniform AC electric field [162]. Therefore, DEP does not require parti-
cles to carry a net charge, and can be performed using biocompatible high-frequency AC
fields that avoid electrolysis.
The DEP force experienced by a spherical particle of radius r and complex permit-
tivity ∗p in a medium of complex permittivity 
∗
m in an electric field ~E is given by
FDEP = 2pir
3mRe
{
∗p − ∗m
∗p + 2∗m
}
∇| ~E|2 where ∗i = i +
σi
jωi
, (4.4)
where the term in brackets is the Clausius-Mossotti (CM) factor fCM . The complex
permittivity can be rewritten in terms of the absolute permittivity  = r0, where r is
the dielectric constant and 0 is the vacuum permittivity; the conductivity σ = σb +
2Ks
r
,
where σb is the bulk conductivity and Ks is the surface conductivity [163]; and the applied
field frequency ω. Thus, the DEP force on a particle of a given size depends on (i) the
difference in dielectric constant and conductivity between the particle and the medium
(captured in fCM), (ii) the frequency of the applied field (which determines the sign
and magnitude of fCM), and (iii) the gradient of the electric field (which depends on
electrode geometry and applied voltage) [162]. In order to achieve the maximum DEP
force possible, the frequency and medium conditions must be optimized to maximize the
magnitude of fCM , while the electric field gradient must be made as sharp as possible
near the path of the object in flow. Notably, for a given particle and medium, fCM may
be either positive or negative depending on frequency, allowing the selection of either
an attractive or repulsive DEP force. Dielectrophoretic sorters have been reported for
droplets [154,155,164,165], cells [166–168], and microparticles [166].
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Figure 4.1: SuperFACS system scheme
4.3 Results and Discussion
4.3.1 SuperFACS system overview
To perform image-based sorting of cells and microparticles, the SuperFACS system
combines three key functions: (i) microfluidic particle manipulation, (ii) high-speed mi-
croscopy, and (iii) real-time image analysis. The scheme for SuperFACS operation is
shown in Figure 4.1. Particles flowing one-by-one through the microfluidic chip are
imaged through an inverted microscope using a high-speed camera. These images are
transferred to a computer in real-time, where a custom program performs image analysis
to detect, analyze, and identify particles in the microchannel. Based on this analysis,
particles classified as “target” objects are actively sorted into a separate collection chan-
nel within the microfluidic chip; this sorting is achieved using DEP actuator electrodes on
the chip, which are attached to a function generator controlled by the analysis computer.
In this way, particles flowing through the SuperFACS chip are imaged, analyzed, and
sorted in a serial manner.
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4.3.2 Microfluidic channel for particle handling and flow control
The sorter chip uses pressure-driven flow to focus the input mixture of microparticles
to a single-file stream for imaging and subsequent sorting at a Y-junction downstream in
the chip (Figure 4.2). The chip consists of two layers: a glass substrate with deposited
microelectrodes, bonded to a PDMS flow channel fabricated using soft lithography (de-
tails in Section 4.5.1). The chip has three fluidic inputs: (1) the sample sheath inlet,
which provides a flow of buffer to propel particles through the chip and prevent particle
settling [169]; (2) the sample injection port, where a concentrated suspension of cells or
microparticles is introduced into the chip; and (3) the focusing sheath inlet, which pro-
vides a secondary stream of buffer that focuses the particles to a narrow range of stream-
lines in the channel and introduces additional longitudinal spacing between subsequent
beads [170] (Figure 4.2b, left inset), thereby enabling consistent actuation. Particles are
imaged before reaching the actuator, which is located upstream of the Y-junction (Figure
4.2b, right inset). By default (that is, without DEP actuation), particles flow into the
waste outlet (bottom of diagram) at the Y-junction, because it is wider and therefore has
slightly lower flow resistance. However, particles actuated by the DEP electrodes will be
deflected away from the electrodes into a streamline leading to the collection outlet (top
of diagram).
Fluid flow through the SuperFACS chip is driven by a simple hydrostatic pressure
source. The two sheath inlets are connected via fluid-filled tubing to an off-chip fluid
reservoir, while the waste and collection outlets are similarly connected to a second fluid
reservoir (the sample injection port is sealed after the introduction of the concentrated
sample solution, and thus no flow occurs through this port during device operation).
The total pressure difference between the inlets and outlets is determined by the relative
heights of the fluid columns in the inlet reservoir and the outlet reservoir, resulting from
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(a) SuperFACS flow channel design
(b) Optical micrograph of assembled SuperFACS chip with flow channel and sorter electrodes.
Arrows indicate direction of flow. Left inset shows magnified view of focusing sheath perfor-
mance for a single 6 µm polystyrene microbead (time-lapse image sequence captured at 30 fps).
Right inset shows magnified view of imaging and actuation regions.
Figure 4.2: SuperFACS flow channel design and layout
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Segment Width (µm) Height (µm) Length (µm) RH (Pa·m−3·s) Q (µL·hr−1)
AC 30 25 615 2.81× 1013 1.41
BC 25 25 1000 6.48× 1013 0.61
CD 30 25 2725 1.25× 1014 2.02
DE 30 25 1750 8.00× 1013 0.77
DF 40 25 1750 4.90× 1013 1.25
Total - - - 1.75× 1014 2.02
Table 4.1: Hydraulic resistance calculations for the channel segments shown in Figure
4.2a for water at 25 ◦C. Example flow rates Q are calculated for the hydrostatic
pressure resulting from a 1 cm height differential between the inlet and outlet fluid
reservoirs. Note that the length of AC does not include the ∼ 700 µm diameter sample
injector port, whose contribution to the total hydraulic resistance between points A
and C is very small.
gravitational force on the two fluid columns; this pressure difference results in net fluid
flow across the device. By simply changing the fluid column height in the reservoirs
(e.g. by adding or removing fluid), we have a highly controllable method of adjusting
the fluid flow rate through the chip; moreover, the reservoir volume is large relative to
the total volume flowed through the chip during an experiment, meaning that flow rates
are stable over time. Notably, because both inlets are connected to a common fluid
reservoir, there is no pressure difference across the inlets and therefore no risk of inlet-
to-inlet backflow; the same is true for the outlets. The relative flow rates through the
individual inlet channels AC and BC and outlet channels DE and DF (Figure 4.2a)
are a result of each channel’s dimensions, which are designed to provide the appropriate
flow ratios at each junction. The channel dimensions and calculated flow rates in each
channel for a 1 cm inlet-to-outlet reservoir height difference is shown in Table 4.1. In
summary, our hydrostatic control scheme enables robust and reliable fluidic operation of
the SuperFACS chip without a complex pumping setup.
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Figure 4.3: Real component of the calculated Clausius-Mossotti factor fCM as a func-
tion of applied field frequency for polystyrene spheres of varying diameter suspended
in deionized water.
4.3.3 Dielectrophoretic actuation
To design and implement an optimal DEP actuator, we mathematically simulated the
effects of particle size, electric field frequency, and electrode geometry on the strength and
polarity of the DEP force. We first calculated the Clausius-Mossotti factor, which deter-
mines the magnitude and direction of the DEP force, for polystyrene spheres of varying
size suspended in deionized water over a range of applied frequencies, using Equation 4.4
(Figure 4.3). These results indicate that DEP is strongly attractive (“positive DEP”,
or pDEP) at lower frequencies, and strongly repulsive (”negative DEP”, or nDEP) at
higher frequencies; moreover, the crossover frequency between pDEP and nDEP is size-
dependent, in agreement with results reported elsewhere [171,172]. Although polystyrene
spheres can undergo both pDEP and nDEP depending on frequency, cells suspended in
salt-containing cell culture media (DMEM, conductivity 1.5 S/m) undergo only negative
DEP, regardless of applied field frequency [173]. Therefore we elected to use an actuator
design based on repulsive nDEP only.
We next used finite element analysis (COMSOL) to simulate the two-dimensional
DEP force field arising from different electrode designs. As expected, smaller electrode
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Figure 4.4: Simulated DEP force experienced by a 6 µm polystyrene particle sus-
pended in deionized water for electrodes spaced 10 µm apart, with a driving field
frequency of 1 MHz and a peak-to-peak voltage of 40 V. Insets show the 1-D force
distribution for slices (white dashed lines) perpendicular to the direction of flow (left
inset) and parallel to the direction of flow (bottom inset). Only the y-component of
the force (e.g., perpendicular to the direction of flow) is shown.
spacings resulted in stronger electric field gradients and higher possible DEP forces. We
chose a 10 µm electrode spacing because it achieves strong DEP deflection, but is still
facile to fabricate using standard photolithography. Figure 4.4 shows the two-dimensional
repulsive DEP force distribution in the channel for electrodes spaced 10 µm apart and
protruding 1 µm into the channel for a 6 µm polystyrene sphere suspended in deionized
water, with an applied potential of 40 VPP at 1 MHz. These simulations indicate that
the DEP force is highly localized at the electrode tips and is strongly position-dependent
in the channel.
Finally, based on these simulated designs, we fabricated and tested the DEP actuator.
The chip’s platinum actuator electrodes (10 µm spacing) are connected to a function gen-
erator and amplifier which provide the necessary AC voltage. We verified the actuator’s
performance for deflecting both polystyrene microparticles (Figure 4.5a) and live human
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(a) Polystyrene microsphere (b) MCF-7 cell
Figure 4.5: Time-lapse image composites of DEP actuation of a polystyrene micro-
sphere in water (a) and a human breast cancer cell in cell culture media (b). Flow
direction is left-to-right.
cancer cells (Figure 4.5b), both with a driving frequency of 1 MHz and a peak-to-peak
voltage of 34 V. For both synthetic microparticles and live cells, the actuators provide
sufficient nDEP repulsive force to deflect the particles or cells into the collection outlet.
4.3.4 Imaging, tracking, analysis, and classification
The assembled SuperFACS chip is mounted on an inverted microscope (Olympus
IX-73), and imaging of the flow channel is performed using a high-speed CMOS camera
(Vision Research Phantom v211). Sorting requires us to obtain image data from the cam-
era in real-time, but commercial high-speed cameras are only designed to store images on
internal memory and transfer them to an external computer after the full image sequence
has been captured 4. To overcome this problem and obtain images in real-time, we wrote
a custom interface that bypasses the camera’s internal storage and delivers image data
directly to the analysis computer. This interface is built around a manufacturer-provided
API that enables direct access to the camera’s “image preview” function over a 1 Gb/s
ethernet connection. Using this approach, we can capture a live stream of 8-bit images
4Specifically, high-speed cameras continuously store data from the image sensor on internal flash
memory using a circular buffer; when triggered by an external computer, the camera then “dumps” the
most recent images from its internal memory to an external computer for storage and analysis.
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from the camera at a resolution of 512× 56 px at a framerate of 250 fps.
This stream of images is continuously processed by an analysis program that performs
three key tasks for each frame: (i) object detection, to determine if an object such as
a microparticle or cell is present in the image; (ii) object tracking, to determine the
object’s location and speed by comparing it to objects detected in previous frames; and
(iii) object classification, in which the relevant image feature for sorting is extracted
and quantified, enabling an eventual sorting decision. The program first uses contrast
thresholding and edge detection to determine if the image is occupied by any objects of
interest, defined as any pixels with sufficiently high contrast compared to the channel
background. If any such edges are present, the program performs image segmentation
using feature-specific algorithms, such as circle or ellipse detection. These detection
algorithms provide the size and location of any objects in the frame; the program then
performs frame-to-frame comparisons to determine if a given object in the present frame
is the same object as detected in the previous frame or is a new object. If the object has
been detected in the preceding frame(s), its position in the channel is compared to its
position in previous frames to determine its displacement. This displacement, combined
with the images’ timestamps, can be used to calculate the object’s velocity. The program
uses this velocity measurement to calculate the precise time delay required for accurate
DEP actuation of the particle downstream. This dynamic velocity tracking is important
because particles passing through the channel can have varying velocities due to the non-
uniform (parabolic Poiseuille flow) cross-sectional flow profile in the channel, resulting in
variable time delays between the imaging region and the actuator for different particles.
Finally, the program compares the extracted image features for a given object to a
user-defined sort criteria, classifying the object as “target” or “non-target” for sorting
downstream. If the object is classified as “non-target,” no action is taken and the object
will flow to the waste channel by default. If the object is classified as “target,” the
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program will use the object’s detected velocity to calculate the appropriate time delay
for activating the DEP electrodes, which are situated a known fixed distance downstream
from the imaging region. The program activates the electrodes by triggering a function
generator using a 5V TTL signal through the computer’s serial port. To facilitate post-
experiment analysis, all images containing detected objects are saved and timestamped.
4.3.5 Size-based sorting of microparticles
As an initial test of our system, we demonstrated real-time sorting of spherical
polystyrene beads based on size. Specifically, a mixture of 13 µm and 8 µm diame-
ter beads suspended in a water/surfactant solution was flowed through the SuperFACS
chip. Bead images were analyzed via edge detection and subsequent circle detection us-
ing the circle Hough Transform [174], which provides the center coordinates and radius
of any detected circular objects (Figure 4.6a). Total time for image acquisition, trans-
fer, and analysis was ∼ 10 ms per image. The program then checked to see whether
the radius measured for the bead in the current image was larger or smaller than the
threshold value for sorting. If the radius met the sort criteria (in this case, was smaller
than the sort threshold), then the program classified the bead as a “target” object for
subsequent actuation and sorting into the collection outlet downstream. For frames with
a bead with a radius above the sorting threshold, the electrodes were not energized and
thus the bead was allowed to pass into the waste outlet. To verify sorter performance,
we used the program’s position tracking ability to monitor each beads center coordinates
both upstream and downstream of the actuator electrodes. The deflected beads exhibit
a large change in their position in the y-direction (i.e., perpendicular to the direction of
flow), providing an automatic means of detecting whether a bead was deflected or not.
Results from this preliminary sort are shown in Figure 4.6a, which plots the observed
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(a) Circular edge (or-
ange and blue outlines)
of polystyrene micro-
spheres detected by the
circle Hough Transform
(b) Size-based sort results
Figure 4.6: Sorting of microparticles based on size
bead deflection due to DEP actuation against the detected bead radius. Only those
beads whose radius was measured to be below the sort threshold of 5 µm were actuated
into the collection channel, as intended.
4.3.6 Shape-based sorting of microparticles
We next used our sorter to perform the more sophisticated task of sorting microparti-
cles based on two-dimensional shape. As a model system, we attempted to sort stretched
polystyrene ellipsoids (described in detail in Chapter 3) based on their aspect ratio. To
do this, we utilized an open-source ellipse detection algorithm in the OpenCV imaging
library based on least-squares fitting [175]; this algorithm provides the major and minor
axis lengths of the fitted ellipse, in addition to center coordinates and rotation angle (Fig-
ure 4.7a. Using this algorithm, we sorted a mixture of stretched ellipsoids and spheres,
with the sorting criteria that only objects with an aspect ratio exceeding 2.0 be deflected
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into the collection channel. Results for this sort, quantified in terms of measured ac-
tuator deflection as in the preceding section, are shown in Figure 4.7b, with the total
number of particles directed into the target and waste outlets shown in Figure 4.7c. As
intended, only those particles with detected aspect ratios greater than 2 were deflected.
However, we note that an appreciable number of detected “target” particles were not
actuated. This was due to suboptimal alignment of the particles as they flowed through
the channel, arising from a faulty focusing sheath inlet. Thus, some of the particles were
already at the “top” of the channel and could not be deflected further. Manual inspec-
tion of the images recorded during this experiment reveal that even for those beads with
AR¿2 where no deflection was detected due to their position at the upper edge of the
channel, the actuator actually did fire at the appropriate time, as revealed by motion of
the particle out of the microscope’s focal plane.
4.3.7 Toward image-based sorting of live cells
Having demonstrated sorting of synthetic particles based on two separate 2-D image
features (detected radius and aspect ratio), we next sought to sort live cells using the
SuperFACS system. However, cells present a number of challenges for image analysis
compared to synthetic microparticles. First, unlike synthetic microparticles, cells can
take on a wide range of irregular shapes and sizes, making it difficult to define a specific
shape or feature a priori for the algorithm to detect, e.g., spheres or ellipses. Second,
when viewed in the brightfield mode, cells have relatively low contrast with the channel
background compared to polystyrene microparticles, due to the similar refractive index
between the cells and their suspension media. This leads to less robust edge detection,
resulting in failed or inconsistent object recognition using the object-oriented shape de-
tection algorithms described above.
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(a) Example fits for ellipsoid microparticles in the flow
channel using the ellipse detection algorithm
(b) Results of shape-based sort (c) Summary of shape-based sort results
Figure 4.7: Sorting of microparticles based on shape
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To overcome these problems, we developed a new cell tracking algorithm for detecting,
tracking, and analyzing cells of arbitrary shape, size, and contrast. At the heart of this
algorithm is a pixel-based contrast analysis scheme, which detects cells by finding groups
of pixels with brightness values different from the channel background. This algorithm
is implemented via a five-step procedure (Figure 4.8). First, the input image undergoes
Gaussian smoothing to minimize the effect of image sensor noise (Figure 4.8a). Second,
all pixels with values close to the average channel background brightness are subtracted,
leaving only those “feature pixels” that are sufficiently brighter or darker than the back-
ground (Figure 4.8b). Next, the channel is downsampled so that immediately proximal
feature pixels are grouped together (Figure 4.8c). Connected component analysis using
an 8-way nearest neighbor algorithm on the downsampled grid is used to identify clusters,
or “connected components,” of feature pixels (Figure 4.8d). Finally, overlapping clusters
are merged using a blob association algorithm, and only clusters above a certain size
cutoff (e.g., the smallest cell size expected) are preserved (Figure 4.8e), in order to reject
contrast artifacts such as debris in the channel.
The final outputs of the cell tracking algorithm are the cluster of contrasting feature
pixels, as well as the rectangular region-of-interest (ROI) bounding the detected cell,
from which the cell’s approximate center coordinates and size may be determined. Fur-
ther cell-specific image analysis, either pixel-based or object-oriented, can subsequently
be performed on either the feature pixels only, or on all pixels contained within the ROI.
There are several key benefits to this algorithm’s design. First, because it is based on
pixel analysis, it is generalizable to potentially any type of object moving through the
flow channel, so long as it has some contrast with the channel background (i.e., is vis-
ible). Second, the algorithm’s computational simplicity makes it very fast to operate,
taking only ∼ 6 ms per frame. Third, it decouples the task of object detection/tracking
from object analysis/classification. Because stable sorter operation requires object de-
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(a) Gaussian smoothed input
(b) Background subtraction
(c) Downsampling and pixel grouping
(d) Connected component analysis (black boxes indicate connected components)
(e) Blob association and artifact rejection, with the final “cell ROI” shown as a black
rectangle containing the white “feature pixels”
Figure 4.8: Contrast-based object tracking algorithm demonstrated for an image of
an RPE cell in the flow channel
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tection and tracking to be performed on each frame, the overall sorter throughput is
coupled to the tracking analysis time per frame. However, object analysis/classification
can be performed on the basis of a single frame. While the relatively fast algorithms
used for shape detection above are not a problem in this regard, more sophisticated cell
classification may require more computationally intensive, and therefore slow, analysis
algorithms. Thus, the fast tracking algorithm described above could be performed for
each frame to maintain a fast framerate; the slower classification algorithm would only
need to be performed once (e.g., on that cell’s first frame in the imaging region).
To demonstrate the utility of our tracking algorithm, we used it to analyze live iPSC-
RPE cells flowing through the device. Transplantation of RPE cells is a promising method
for the treatment of age-related macular degeneration [176, 177], but therapeutic use
requires highly pure populations of mature, fully-differentiated RPE cells, indicated by
their degree of pigmentation. However, highly pure discrimination of pigmented versus
unpigmented RPE cells is unfeasible using traditional FACS alone. We therefore used
a pixel-based algorithm to classify RPE cells flowing through the SuperFACS device as
either pigmented or unpigmented. To do this, we first used our contrast-based tracking
algorithm to detect and track the cells as they flowed through the channel. For each cell
image, we then counted the number of feature pixels within each cell that are brighter
than the average background pixel value, as well as the number of pixels that are darker.
By plotting the dark pixel count versus bright pixel count for each cell, we can define a
dividing line differentiating pigmented cells from unpigmented cells (Figure 4.9). This
simple algorithm requires further optimization and testing, but is a promising approach
to perform image-based sorting of RPE cells in the future.
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Figure 4.9: Pixel-based algorithm for classification of RPE cells based on pigmen-
tation. Small faded circles indicate analysis of individual frames as the cell flowed
through the channel, while large bright circles indicate the mean values for a given
cell across all its frames (error bars indicate S.D.). A representative image for each
numbered cell is shown on the right.
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4.3.8 Discussion
In this work, we have showed promising preliminary results toward an image-based cell
sorter. We demonstrated that the SuperFACS system’s unique combination of microflu-
idic particle manipulation and real-time image processing enables image-based sorting
of synthetic microparticles based on a variety of two-dimensional features. We also de-
veloped a novel object tracking algorithm to enable the analysis and sorting of a wide
variety of cell types, and we demonstrated preliminary results for a pixel-based classifi-
cation algorithm for iPSC-RPE cells. These proof-of-concept results should be followed
up with a real-time sort of RPE cells based on pigmentation.
A critical performance metric for the SuperFACS system is its sorting throughput.
The overall system sort rate depends on a number of limiting factors, including the image
capture rate, image transfer rate, image analysis time, and actuator speed. The current
throughput bottleneck is image analysis time, which takes roughly 5-10 ms per frame
using our existing unoptimized algorithms. This currently limits our practical sorter
throughput to a rate of < 100 objects/s. Future work utilizing dedicated image analysis
hardware through an FPGA would be able to lower this analysis time by 2-3 orders
of magnitude [158, 178]. Image transfer rate is also presently limited to about 250 fps;
again, high-speed image transfer interfaces and dedicated image acquisition hardware
(e.g., a framegrabber FPGA) can increase this throughput 10-100 fold. As imaging
and analysis rates are increased, the DEP actuator may not be able to deflect cells
sufficiently quickly without applying large electric fields that could damage cell viability.
To overcome this problem, we could employ gentler methods of cell manipulation capable
of rapid switching, such as surface acoustic wave actuators [179, 180] that can actuate
microparticles and cells at rates approaching 20,000 Hz. With all of these potential
improvements combined, we estimate that a final sorter throughput of ∼ 1000 cells/s
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could be feasible.
One key limitation of the SuperFACS system in its current iteration is its inability to
perform fluorescence imaging. Because of the very brief exposure times employed for high-
speed imaging, we are currently limited to capturing brightfield images only; well-resolved
fluorescence images would be impossible to obtain for all but the brightest fluorescent
dyes. This problem could be addressed by utilizing high-gain image sensor techniques
such as time-delay integration [153,181], but such hardware-based techniques are difficult
to implement on commercially available high-speed image sensors. Brightfield imaging
still contains a wealth of phenotypic information —especially when “brightfield-visible”
labeling strategies are used, such as antibody-conjugated high-contrast microparticles
that bind to specific surface proteins on a cell of interest [182] —but the overall usefulness
of the SuperFACS system will be limited without fluorescence imaging capabilities.
Another key challenge for image-based cell sorting is the determination of the ideal
image analysis and classification criteria to use in order to enrich cells expressing the de-
sired phenotype. While certain cases, such as RPE pigmentation, have an obvious visual
phenotype on which sorting may be based, many other cellular systems have far more
subtle differentiating features separating “target” and “non-target” cell types. Future
work in image-based sorting should leverage recent advances in the field of high-speed
imaging flow cytometry which have employed machine learning approaches to identify
relevant image features for cell classification [147,151,182].
4.4 Conclusion
We have demonstrated promsing proof-of-concept results for image-based cell sorting,
which has the potential to become a powerful tool for biological research, biotechnology,
and biomedicine. By combining the rich information content of traditional microscopy
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with the throughput and population-level data afforded by flow cytometry, image-based
sorters could enable new insights into subtle cellular processes and new approaches to
cellular therapeutics.
4.5 Experimental Methods
4.5.1 Chip fabrication and assembly
Microelectrodes were deposited on glass wafers (500-µm thick, 100 mm diameter) via
contact lithography and electron beam deposition (200 Ti, 1800 Pt). The wafer was
then diced to form individual glass substrates with electrodes. A master mold for the
microfluidic flow channels was fabricated via contact lithography on a silicon substrate
using SU-8 negative photoresist. Polydimethylsiloxane, or PDMS (Sylgard 184, Dow-
Corning), was then mixed and poured over the mold. After being partially cured at 80
◦C for one hour, we peeled the PDMS off of the mold and punched 1.5 mm diameter
holes to form the sample sheath inlet, focusing sheath inlet, and outlets. A via to the
sample injection port was formed using a 0.7 mm hole punch. The bottom (channel-
imprinted) side of the PDMS and the top (electrode) surface of the glass substrate were
both briefly exposed to an O2 plasma (BD-20AC Laboratory Corona Treater, ETP Inc.).
Immediately after, the plasma-treated PDMS and glass substrate were aligned using
an inverted microscope to ensure that the electrode tips were located directly in the
center of the microchannel ∼ 5 microns upstream of the sorting junction, and were
subsequently placed into contact and cured for several hours at 80 ◦C, facilitating an
irreversible covalent bond between the glass and PDMS. Finally, wires leading to a BNC
connector were soldered to the electrode contact pads to allow for connection to the
function generator.
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4.5.2 Fluidic connections
Fluidic vias to the sample sheath inlet, focusing sheath inlet, and waste and collection
outlets were formed via 1 cm lengths of 0.02” I.D. / 0.06” O.D. Tygon tubing (Saint-
Gobain Performance Plastics). These vias were friction-fit into the ends of 20 cm lengths
of 0.04” I.D. / 0.07” O.D. Tygon tubing, which ultimately were passed into the inlet
reservoir (for the sample sheath and focusing sheath inlets) or the outlet reservoir (for
the collection and waste outlets). The sample injection port was attached to a 5 cm
length of 0.76-mm O.D. / 0.30-mm I.D. PTFE tubing (Cole-Parmer), which was filled
with the suspension to be sorted and capped with a small plunger to enable injection
into the chip. The inlet and outlet reservoirs contained deionized water.
4.5.3 Electronic instrumentation
The sorter chip’s electrodes were connected to a high-frequency function generator
(AFG320, Tektronix) and a custom-built power amplifier. In order to achieve maximum
dielectrophoretic deflection at the electrodes, a DEP driving signal of 1 MHz at 34 V
peak-to-peak amplitude was employed.
4.5.4 Microparticles and suspensions
Size-based sorting of spherical microparticles was performed using 8 and 13 µm diam-
eter polystyrene microbeads (Fisher). Stretched polystyrene ellipsoids were produced in
the same manner as was described in Chapter 3. All synthetic particles were suspended
in deionized water containing 1% Tween 20 (Sigma Aldrich) as a surfactant. Particle
suspensions were vortexed, sonicated, and passed through a 20 µm filter prior to use in
the chip.
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4.5.5 Cell protocols
MCF-7 cells for actuator testing were revitalized from liquid nitrogen storage and sus-
pended in 1 mL of culture media containing Eagle’s minimum essential medium (EMEM)
supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin. All
culture reagents were purchased from ATCC (Manassas, VA). Cells were then incubated
in T-150 cell culture asks (Fisher Scientic) with 30 mL of culture media until they reached
90% conuence. The cells were washed with Dulbecco’s phosphate-buered saline (DPBS;
ATCC), released using 5 mL of trypsin/EDTA solution (ATCC), and then collected and
pelleted via centrifugation at 400g for 10 min. Live cells were resuspended in 10 mL of
EMEM. Retinal pigment epithelium cells produced from induced pluripotent stem cells
(iPSC-RPE) were provided by Dr. Monte Radeke of the UCSB Neuroscience Research
Institute.
Prior to sorting, cells were suspended in Dulbecco’s modified Eagle medium (DMEM)
at a concentration of 1 × 105 to 1× 106/ml. Immediately prior to entering the chip, all
cell suspensions were gently mixed with a 1 mL pipette and subsequently passed through
a 20 µm filter.
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Chapter 5
Contamination-Resistant
Loop-Mediated Isothermal
Amplification for Genetic Pathogen
Detection
5.1 Introduction
1 Rapid, sensitive, and specific genetic amplification methods have become an indis-
pensable tool for a wide array of applications including disease diagnostics [183–185], food
safety testing [186–188], and environmental monitoring [189, 190]. In particular, loop-
mediated isothermal amplification (LAMP) [191] has emerged as a popular technique
because of its sensitivity, specificity and isothermal reaction conditions, which obviate
1The first portion of this chapter was previously published in Hsieh, K., Mage, P.L., Csordas,
A.T., Eisenstein, M., Soh, H.T. Simultaneous elimination of carryover contamination and detection of
DNA with uracil-DNA-glycosylase-supplemented loop-mediated isothermal amplification (UDG-LAMP).
Chemical Communications 50, 3747-9 (2014).
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the need for specialized thermal cycling equipment [191, 192]. Unfortunately, LAMP’s
potent amplification mechanism, while making the assay highly sensitive, also renders
it highly susceptible to carryover contamination, wherein amplified DNA products from
previous LAMP reactions become templates for re-amplification that lead to false positive
results [193]. Importantly, there is currently no effective means for eliminating LAMP
carryover contamination. Thus, laboratories using LAMP can only rely on careful (and
failure-prone) preventative methods, because once contamination occurs, the process of
decontamination is costly and time-consuming, sometimes requiring a complete redesign
of the assay.
Toward a strategy to eliminate carryover contamination, a number of groups have ex-
plored selective enzymatic digestion of contaminant amplicons (see references [194, 195]
for extensive reviews). For example, the pioneering work by Longo and coworkers [196]
utilized deoxyuridine triphosphate (dUTP) for polymerase chain reaction (PCR) amplifi-
cation, such that all amplicons incorporated uracil bases. Prior to performing subsequent
PCR reactions, any uracil-containing PCR amplicons from previous reactions (i.e., carry-
over contaminants) were digested with uracil-DNA-glycosylase (UDG) [197], an enzyme
that specifically removes uracil bases in uracil-containing DNA but has no effect on nat-
ural, thymine-containing DNA [197, 198]. This enzyme degraded uracil-containing PCR
amplicons from previous reactions, preventing them from amplifying while leaving only
the target DNA intact for amplification. Crucially, this assay is effective because it is
a one-pot reaction that can be performed in a closed-tube vessel; it is well known that
opening the reaction vessel during the amplification reaction dramatically increases the
risk of reintroducing contaminants from the environment [193].
Recently, He and co-workers have shown that dUTP can also be incorporated into
LAMP reactions and that UDG can be used to degrade uracil-labeled LAMP amplicons in
a similar manner to PCR [199,200]. Unfortunately, the assay requires UDG digestion and
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LAMP amplification to be performed in separate reactions, which necessitates opening
the reaction vessels and exposing them to carryover contaminants in the environment.
This key limitation has prevented the translation of this method into a practically useful
assay.
5.2 Results and Discussion
5.2.1 Overview of UDG-LAMP Assay
Motivated by this critical unmet need, we report the first integration of LAMP ampli-
fication with UDG digestion in a one-pot, closed-vessel reaction to eliminate false-positive
results arising from carryover contaminants. Our uracil-DNA-glycosylase-supplemented
LAMP (UDG-LAMP) assay requires only two additional components relative to conven-
tional LAMP and eliminates carryover contamination in two stages. In the first stage,
we add dUTP into all LAMP reaction mixtures so that uracil is incorporated into the
amplicons (Figure 5.1; stage 1). To enhance dUTP incorporation, which is critical to
the success of this method, we have replaced the Bst DNA polymerase commonly used
in conventional LAMP reactions with Bst 2.0 DNA polymerase [201]. In the second
stage, which applies to all subsequent reactions, we perform UDG digestion and the
LAMP reaction in a one-pot process. Specifically, prior to amplification, we treat the
reaction mixture with a heat-labile UDG enzyme [202,203] (Figure 5.1; stage 2) at room
temperature for 5 minutes. The UDG enzyme selectively cleaves uracil bases from any
contaminating LAMP amplicons, leaving behind abasic sites [204], while uracil-free target
DNA remains completely unaffected. In the immediately ensuing LAMP reaction, these
abasic sites block replication by DNA polymerases and cause rapid degradation of the
carryover contaminants via hydrolysis at the phosphate backbone [196, 205], effectively
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Figure 5.1: Overview of uracil-DNA-glycosylase-supplemented loop- mediated isother-
mal amplification (UDG-LAMP). UDG-LAMP eliminates carryover contamination in
two stages. First, all LAMP reactions are performed in the presence of dUTP and
Bst 2.0 DNA polymerase, such that all amplicons contain uracil bases. All subsequent
LAMP reactions are then treated with UDG to eliminate carryover contaminants by
specifically removing uracil from amplified products from previous LAMP reactions,
while having no effect on natural DNA. During the LAMP reaction, the digested con-
taminants are degraded and the UDG enzyme is heat-inactivated, ensuring that only
the target is amplified.
preventing them from re-amplification.
Critically, the use of our heat-labile UDG enables the UDG-LAMP assay to be per-
formed in a single closed vessel, because the enzyme is rapidly and automatically deacti-
vated when the LAMP reaction is performed at an elevated temperature (i.e., ◦65 C). In
this way, genuine amplicons subsequently produced from the target during the reaction
are not digested, allowing amplification to proceed normally (Figure 5.1; stage 2). Finally,
once amplification is complete, amplicons from the UDG-LAMP reaction can be detected
with standard methods such as gel electrophoresis and fluorescence. Here, we used com-
mercially available calcein fluorescence reagents to detect UDG-LAMP amplicons in a
closed-tube fashion, further ensuring a contamination-free read-out of the reaction [193].
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Samples that have undergone amplification exhibit strong calcein fluorescence that is
directly observable under ambient light or UV irradiation.
5.2.2 LAMP with dUTP and Bst 2.0 DNA polymerase
To demonstrate the utility of UDG-LAMP, we used the assay to detect genomic DNA
from Salmonella enterica serovar Typhimurium (S. Typhimurium), a bacterial pathogen
that causes food poisoning, using a pre-existing set of six primers that target the invA
gene [206] (see Methods for primer sequences). We first confirmed that robust LAMP
reactions could be achieved with Bst 2.0 DNA polymerase incorporating dUTP into
LAMP amplicons in the presence of the UDG enzyme. To test this, we added either dUTP
alone or both dUTP and UDG to the reaction mixture (see Methods for details), along
with 2104 copies of purified S. Typhimurium genomic DNA as target. After incubating
the reaction for 60 minutes at 65 ◦C, we observed strong calcein fluorescence in both
target-containing reaction tubes under UV illumination, confirming that both samples
amplified successfully with Bst 2.0, even in the presence of the UDG enzyme (Figure
5.2A).
5.2.3 UDG digestion of carryover contaminant
We next verified that UDG is capable of digesting carryover contaminants with high
efficiency. To demonstrate this, we performed a UDG-free LAMP reaction supplemented
with dUTP, and then added between 100 zeptograms (1 × 10−19 g) and 1 femtogram
(1 × 10−15 g) of amplicon DNA from this reaction into a new set of target-free UDG-
LAMP reactions to simulate carryover contamination. In parallel, we also added the same
amounts of contaminants to a set of LAMP reactions without UDG as controls. We esti-
mated the amount of carryover contaminants by mass because LAMP reactions produce
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Figure 5.2: Addition of UDG preserves robust LAMP reactions and achieves effec-
tive digestion of carryover contaminants. (A) Bst 2.0 DNA polymerase successfully
incorporated dUTP into amplicons both in the presence and absence of UDG, as indi-
cated by the bright calcein fluorescence from the reaction mixture. Control reactions
with no target DNA exhibited minimal fluorescence. (B) UDG-free reactions yielded
amplification from as little as 1 attogram of carryover contaminants (top row). In
contrast, UDG treatment effectively eliminated such amplification, even at 100-fold
higher contaminant concentrations (bottom row).
amplicons of various lengths, rendering a priori estimates of copy number impractical
(see Methods for calculation).
In samples without UDG, we observed amplification from as little as 1 attogram of
carryover contaminant (Figure 5.2B, top row). This demonstrates that a source contam-
inant equivalent to a 0.2µm-diameter aerosol droplet (4 × 10−18 L) —which cannot be
efficiently blocked by fibrous pipette tip filters [207,208] —was sufficient to contaminate
new reactions. These results clearly illustrate the danger of carryover contamination in
LAMP reactions, where even miniscule amounts of contaminant can produce unwanted
amplification. In contrast, UDG prevented amplification of up to 100-fold higher concen-
trations of carryover contaminant DNA (Figure 5.2B, bottom row), and calcein fluores-
cence was only observed in the sample containing the highest tested dose of contaminants
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(1 femtogram DNA).
5.2.4 UDG prevents false-positive amplifications
Finally, we show that UDG-LAMP can significantly reduce false-positive results due
to carryover contaminants. To do so, we set up UDG-free LAMP reactions and UDG-
LAMP reactions with and without target DNA, and deliberately doped these samples
with ∼ 10 attograms of carryover contaminant amplicons, simulating a moderate level of
contamination (e.g., resulting from multiple aerosol droplets too small to be sequestered
by pipette tip filters). Without UDG, we observed fluorescence in the no-target negative
control sample (Figure 5.3A, left), yielding a false-positive signal indistinguishable from
true positive signals obtained in the presence of target DNA. In contrast, UDG-LAMP
eliminated these false positives, and we could clearly distinguish the negative control
from samples containing as little as 4 × 103 copies of target DNA (Figure 5.3A, right).
This difference is even more striking in gel electrophoresis results, where the strong false-
positive amplicon bands arising from contaminant amplification products in the no-UDG
sample (Figure 5.3B, lane 1) is virtually eliminated with UDG-LAMP (lane 4).
5.2.5 Extending UDG-LAMP to achieve contamination-resistant
real-time LAMP
Recent advancements in real-time LAMP assays [201,209–214] offer quantitative tar-
get copy-number information that is useful for accurate disease diagnoses. Unfortunately,
carryover contamination produces false products that can overwhelm the true products
generated from the target DNA, giving rise to inaccurate results in copy number. At
present, there is no effective means for eliminating LAMP carryover contamination in
real-time LAMP assays. We therefore sought to extend our UDG-LAMP strategy to con-
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Figure 5.3: UDG-LAMP reduces false-positive detection due to carryover contam-
ination. (A) In the presence of 10 attograms of contaminant DNA, a target-free
standard LAMP reaction (left) generates a fluorescent signal indistinguishable from
that generated by samples containing 4 × 103 or 2 × 104 copies of target DNA. In
contrast, UDG treatment (right) eliminates this false-positive signal, restoring the
accuracy of the assay. (B) Gel electrophoresis clearly demonstrates the effectiveness
of UDG-LAMP in eliminating false-positives, with virtually no amplification detected
in a contaminant DNA-only sample (lane 4).
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fer contamination resistance to real-time LAMP assays. Our Contamination-Resistant
Real-time LAMP (CORR-LAMP), the first real-time LAMP assay that is immune to
carryover contamination, combines UDG-LAMP with real-time amplification monitoring
based on DNA-intercalating reporters, leveraging a detection approach that has been
widely-adopted in both fluorescent [215] and electrochemical [216] real-time monitoring
of LAMP reactions. In doing so, CORR-LAMP can discriminate DNA samples with
different copy numbers even in the presence of substantial amounts of carryover contam-
ination (Figure 5.4A). As a further benefit, we have integrated the entire CORR-LAMP
assay onto a multiplexed microfluidic device such that multiple samples can be processed
simultaneously with excellent reproducibility.
Our CORR-LAMP integrates electrochemical real-time LAMP [217–222] with UDG
treatment (Figure 5.4B). As in UDG-LAMP, CORR-LAMP incorporates dUTP into the
LAMP reaction so that all amplification products contain uracil bases, and at the begin-
ning of each reaction, any uracil-tagged carryover contaminants from previous reactions
are digested away by the UDG enzyme (Figure 5.4B, left). We then initiate the LAMP
reaction with a DNA-intercalating electrochemical reporter (methylene blue, MB) added
to the sample. In the initial phase of the amplification, MB molecules freely diffuse and
transfer electrons to the gold working electrode in the device, producing a high redox
current. Importantly, because the reaction is performed at 66 ◦C, the thermally labile
UDG enzyme is automatically deactivated, which prevents digestion of dUTP-containing
amplicons produced from the target DNA. As the amplification progresses, more MB
molecules intercalate into the double-stranded LAMP amplicons, thereby decreasing the
electrochemical current at the working electrode (Figure 5.4B, right). We continuously
monitor the MB redox current throughout the reaction; when this current is plotted
as a function of time, a successful amplification is indicated by a sigmoidal decrease in
current [218].
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Figure 5.4: (A) Carryover contamination prevents accurate discrimination between
samples with different copy numbers of target DNA (top). CORR-LAMP can accu-
rately discriminate samples containing different copy numbers of target DNA, even
with carryover contamination (bottom). (B) CORR-LAMP integrates electrochemical
real-time LAMP with enzymatic digestion of carryover contaminants in a “one-pot”
assay. As in UDG-LAMP, the assay incorporates dUTP into the LAMP reaction to
chemically differentiate amplicons from natural target DNA. At the beginning of the
reaction, the UDG enzyme digests uracil-containing amplicons while leaving natural
target DNA untouched. The reaction mixture is then heated to the LAMP reaction
temperature (i.e., 66 ◦C), at which point the heat-labile UDG is automatically deac-
tivated and LAMP amplification commences. As amplification progresses, more MB
molecules intercalate into the double-stranded LAMP amplicons and become less effi-
cient at transferring electrons at the working electrode in the device. Amplification is
indicated by a sigmoidal decrease in current when plotted as a function of time. (C)
CORR-LAMP is performed in a sealed microfluidic device with three identical but in-
dependent reaction chambers to enable simultaneous triplicated measurements. The
electrodes are coated with a thermally-stable monolayer of 11-mercaptoundecanoic
acid (MUA) that facilitates stable MB current measurements.
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In addition to digestion of contaminants, the CORR-LAMP assay is designed as a
“one-pot” reaction and is performed in a sealed microfluidic device, which further avoids
re-exposing the sample to contaminants during the reaction. Our device integrates three
reaction chambers, each equipped with a set of microfabricated electrodes (Figure 5.4C).
This design allows us to obtain triplicate measurements from a sample in a single run (or
to include internal positive and negative controls, though not used as such in the current
work). To protect the electrodes from potential non-specific adsorption of MB [223], we
coat the electrodes with a monolayer of 11-mercaptoundecanoic acid (MUA). Notably,
this thermally stable monolayer [224,225] remains intact even at high temperatures, thus
enabling accurate and reproducible electrochemical real-time measurements. After load-
ing the sample, primers, and reagents into the device, we incubate the mixture at room
temperature for 5 minutes to allow complete UDG digestion of carryover contaminants.
We then heat the device to 66 ◦C to commence the LAMP reaction while simultaneously
initiating a series of electrochemical measurements to achieve real-time detection.
5.2.6 CORR-LAMP assay validation
We first demonstrated robust target amplification and electrochemical real-time mon-
itoring in CORR-LAMP by analyzing a contamination-free sample containing 2 × 104
copies of the S. Typhimurium genomic DNA. This reaction yielded a sigmoidal decrease
in the time-course current trace over the course of amplification as expected (Figure
5.5a, red), signaling successful production of LAMP amplicons that led to intercala-
tion of MB into the amplicons, as previously observed [218]. In contrast, a no-target
control yielded no such decrease in current (Figure 5.5a, black), and produced a small
background drift, presumably due to weak interaction between MB and single-stranded
LAMP primers [226–228] and/or gradual dissociation of MB initially entrapped in MUA
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(a) The CORR-LAMP sample with 2 × 104
copies of S. Typhimurium genomic DNA pro-
duces a sigmoidal-shaped decrease in the time-
course current trace (red). This indicates
successful production and detection of uracil-
tagged LAMP amplicons. In contrast, the no-
target control produces no amplicons and thus
yields a small, background drift (black).
(b) Real-time LAMP reactions containing S. Ty-
phimurium genomic DNA target without (black
current trace) and with UDG (red current
trace) show comparable target amplification,
as both reactions yield similar amplification-
specific, sigmoidal decrease in the MB redox cur-
rent traces. The similar current traces indicate
that UDG does not affect the LAMP reaction ef-
ficiency and that UDG is effectively de-activated
during the LAMP reaction.
Figure 5.5: Target amplification in CORR-LAMP
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Figure 5.6: The UDG enzyme in the CORR-LAMP reaction effectively digests car-
ryover contaminants that deliberately doped into the reaction mixture, preventing
false-positive amplification (orange). This is evident by the current trace that is vir-
tually indistinguishable from a reaction performed without contaminants or targets.
In contrast, the reaction without UDG results in a false-positive as shown by the
current decrease due to amplification of contaminants (gray).
monolayer [223,229]. Importantly, we confirmed that the addition of UDG did not affect
the efficiency of LAMP, as the reactions containing the same copy number of DNA target
performed with and without UDG yielded similar current traces (Figure 5.5b). This re-
sult also indicates that the UDG is effectively de-activated during the LAMP reaction if
this were not the case, UDG would digest the amplicons and there would be no sigmoidal
decrease in the current trace.
The UDG enzyme can efficiently digest the carryover contaminants, preventing false-
positive amplifications. To demonstrate this, we compared two “contaminated,” no-
target control reactions either with or without UDG treatment. Specifically, we deliber-
ately doped ∼ 10 attograms of carryover contaminants to both reaction mixtures, again
representing a moderate level of contamination typically carried by aerosol droplets. The
reaction without UDG resulted in false-positive results as shown by the current decrease
caused by the amplification of the contaminants (Figure 5.6, gray), which is similar to
the results obtained with target DNA. In contrast, the incorporation of UDG effectively
prevented false positive amplification (Figure 5.6, orange), resulting in current traces
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that were virtually indistinguishable from a reaction performed without any templates
(i.e., either contaminants or targets).
5.2.7 CORR-LAMP enables copy number discrimination in con-
taminated samples
Towards a fully quantitative, contamination-resistant LAMP assay, we performed a
proof-of-concept experiment to test whether CORR-LAMP can discriminate samples with
different amounts of target DNA in the presence of carryover contamination. Specifically,
we prepared two contaminated samples containing either a low dose (4 × 103 copies)
or high dose (2 × 104 copies) of target DNA. We then compared CORR-LAMP with
standard real-time LAMP (without UDG). Without UDG, it was not possible to dis-
tinguish between the two samples containing different copy numbers of target DNA, as
they yielded essentially indistinguishable current traces (Figure 5.7A, left). In contrast,
CORR-LAMP yielded two distinct current traces from the two contaminated samples
(Figure 5.7A, right); the sample containing the higher dose of target DNA (Figure 5.7A,
right, red) took shorter time to accumulate sufficient amplicons and cause the sigmoidal
decrease in current than the sample containing the lower dose of target DNA (Figure
5.7A, right, blue), as expected.
Finally, we utilized the “time-to-threshold” (tTH) metric [218] to discriminate the
relative amount of target DNA in the contaminated samples. The tTH is defined as
the time point at which amplification is most efficient in a reaction, and it is obtained
by locating the local minimum in the current derivative trace (dI/dt), where the MB
current decreases most rapidly. Furthermore, we obtained triplicate measurements from
our microfluidic device for each of the four samples (low or high target dose, with or
without UDG), and calculated the mean and standard deviation of the tTH values (Figure
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5.7B). The two samples amplified without UDG yielded statistically indistinguishable tTH
values of 12.3 ± 0.6 min for the high-dose sample and 11.7 ± 0.6 min for the low-dose
sample (Figure 5.7B, left), confirming that quantitative discrimination of contaminated
samples is not possible due to the carryover contamination (likely because the carryover
contaminant had become the more “dominant” amplification template relative to the
target). In contrast, CORR-LAMP resulted in a large, statistically significant difference
in tTH values: 14.3±2.5 min for the high dose sample and 25.3±2.3 min for the low dose
samples (Figure 5.7B, left), demonstrating the potential of CORR-LAMP to discriminate
between samples with different copy numbers of target DNA even when contaminated.
5.3 Conclusion
In sum, we report the first integration of LAMP amplification with UDG digestion
in a one-pot, closed-vessel reaction to greatly reduce false-positives from carryover con-
taminants. As a demonstration, we used UDG-LAMP to detect genomic DNA from the
pathogen S. Typhimurium, and showed that we can readily eliminate false-positives aris-
ing from volumes of contaminant DNA equivalent to the aerosol droplets that may be
encountered in a typical diagnostic or experimental setting. Currently, our limit of de-
tection is approximately ∼4000 copies of target DNA in the presence of 10 attograms of
carryover contaminants. Although this is a useful limit of detection, it nevertheless sug-
gests some inhibition of LAMP by the UDG enzyme. We believe we can further improve
the limit of detection by taking measures to reduce UDG inhibition of amplification. This
could be achieved by adjusting the dose of UDG, adding a UDG-inactivation step at an
intermediate temperature prior to initiating the LAMP reaction, or exploring alterna-
tive UDG enzymes that may be more susceptible to thermal deactivation. With these
improvements to detection sensitivity, and with the demonstrated contamination elimina-
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Figure 5.7: CORR-LAMP can discriminate samples with different amounts of tar-
get DNA in the presence of carryover contamination (A) Without UDG treatment,
carryover contamination prevents real-time LAMP from discriminating between sam-
ples with different amounts of target DNA. In contrast, CORR-LAMP successfully
discriminates these two samples, resulting in clearly distinct current traces for the
samples with high and low doses of target DNA (right). (B) When analyzed by re-
al-time LAMP without UDG treatment, contaminated samples with different target
copy numbers yielded statistically indistinguishable tTH values, confirming that quan-
titative detection of target in contaminated samples is impossible without UDG (left
column). In contrast, CORR-LAMP enables statistically significant discrimination
of contaminated samples with different target copy numbers (right column). tTH for
each current derivative trace is indicated by a vertical line, and overall tTH for each
sample is reported as mean ± S.D. 109
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tion capability of our assay, we believe UDG-LAMP has the potential to greatly expand
the utility of LAMP-based target detection in a wide variety of laboratory and point-
of-care settings. We further demonstrated a strategy to address the unsolved problem
of obtaining copy-number information for target DNA in a sample laced with carryover
contamination. We achieved this by integrating real-time electrochemical detection with
UDG treatment in a “one-pot” reaction, which can be performed in a sealed microfluidic
device that offers highly reproducible, triplicate results in a single experiment. As a
demonstration, we used our system to quantitatively discriminate samples that contain
2 × 104 and 4 × 103 copies of genomic DNA of a bacterial pathogen, which were laced
with a substantial amount (10 attograms) of carryover contaminants.
This ability to discriminate between contaminated samples with varying amounts
of target DNA is a crucial first step toward contamination-resistant DNA quantitation,
but a number of improvements must be made to develop CORR-LAMP into a reliable,
fully quantitative real-time assay. First, a calibration curve needs to be developed by
measuring the tTH for a number of samples containing a broader range of known initial
target DNA copy numbers (as reported by Mori et al. [209]), enabling the determination
of target copy number for samples with unknown quantities of target DNA based solely
on tTH measurement. Second, the calibrated CORR-LAMP assay should be validated
by analyzing samples using a well-characterized secondary measurement technique such
as real-time quantitative PCR. Finally, the impact of varying amounts of contaminant
should be evaluated to ensure robust assay performance under a variety of environmental
conditions. The success of these improvements could pave the way for robust and quan-
titative genomic detection methodology, which is “immune” to carryover contamination,
and they are topics of current investigations.
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5.4 Experimental Methods
5.4.1 Materials and Reagents.
LAMP reaction reagents, including Loopamp DNA Amplification Kit and Loopamp
Fluorescent Detection (FD) Reagent, were purchased from SA Scientific (San Antonio,
TX). LAMP DNA primers were ordered from Integrated DNA Technologies (Coralville,
IA). Bst 2.0 DNA polymerase and low molecular weight DNA ladder were obtained from
New England Biolabs (Ipswich, MA). Cod uracil-DNA-glycosylase (UDG) was purchased
from ArcticZymes (Plymouth Meeting, PA). 2’-deoxyuridine-5’-triphosphate (dUTP)
sodium salt was acquired in the form of a 100 mM solution from Affymetrix (Santa
Clara, CA). Nuclease-free water (not DEPC-treated) and TE buffer (10 mM Tris and
1 mM EDTA, pH 8.0) were purchased from Life Technologies (Carlsbad, CA). Purified
Salmonella enterica serovar Typhimurium genomic DNA was acquired from ATCC (Man-
assas, VA) and reconstituted in-house in TE buffer at 20 ng/L, as measured by a Nan-
oDrop 1000 Spectrophotometer (Thermo Fisher Scientific, Wilmington, DE). Agarose
(Low-EEO/Multi-Purpose/Molecular Biology Grade) was purchased from Fisher BioRe-
agents (Fair Lawn, NJ) and TBE buffer (0.089 M Tris base, 0.089 M boric acid (pH
8.3) and 2 mM Na2EDTA) was purchased from National Diagnostics (Atlanta, GA).
GelStar nucleic acid gel stain was obtained from Lonza (Basel, Switzerland). Reagent-
grade chemicals, including 11-mercaptoundecanoic acid (MUA), sulfuric acid (H2SO4),
and methylene blue (MB) were purchased from Sigma-Aldrich (St. Louis, MO) and used
without further purification.
5.4.2 Primer sequences for S. Typhimurium
Each primer is shown with its sequence (5’ to 3’):
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FIP: GACGACTGGTACTGATCGATAGTTTTTCAACGTTTCCTGCGG
BIP: CCGGTGAAATTATCGCCACACAAAACCCACCGCCAGG
F3: GGCGATATTGGTGTTTATGGGG
B3: AACGATAAACTGGACCACGG
FL: GACGAAAGAGCGTGGTAATTAAC
BL: GGGCAATTCGTTATTGGCGATAG
5.4.3 UDG-LAMP Reaction Assembly.
The reaction mix was assembled in a laminar flow hood in a laboratory separate from
where the amplification and the detection steps were performed to prevent unwanted
carryover contamination. A typical UDG-LAMP reaction mix (9 L) contained the fol-
lowing: 1 Loopamp DNA Amplification Reaction Mix (20 mM Tris-HCl, 10 mM KCl, 8
mM MgSO4, 10 mM (NH4)2SO4, 0.1% Tween20, 0.8 M betaine, and 1.4 mM dNTP), 1.4
mM dUTP (1:1 dUTP-to-dTTP ratio), 0.2% BSA, 3.2 M each of FIP and BIP primers,
0.4 M each of F3 and B3 primers, 0.8 M each of LF and LB primers (see Supporting
Information Table S1 for sequences), 0.36 L FD reagent, 0.64 U/L Bst 2.0 DNA poly-
merase, 0.005 U/L UDG, 0.5 L genomic target DNA diluted from the stock with TE
buffer to obtain the desired concentration, and 0.4 L contaminant DNA diluted from
previous LAMP reactions with TE buffer to obtain the desired concentration. Of note,
during the reaction assembly, the reagents were kept cold with a 96-well PCR cold block
(Eppendorf, Hauppauge, NY). Also, the two enzymes were added only after the other
reagents had been assembled and well mixed (except for targets and contaminants) in
order to ensure the activity of these enzymes. Finally, contaminant DNA was added in a
112
Contamination-Resistant LAMP for Genetic Pathogen Detection Chapter 5
fume hood in a separate laboratory to prevent exposing the reaction preparation facility
with unwanted carryover contamination.
5.4.4 Fabrication of CORR-LAMP Microfluidic Chips
CORR-LAMP chips were assembled from three modular, separately fabricated layers
—the gold electrode substrate, the chamber layer, and the fluidic via substrate —similar
to previously described methods [218]. For the gold electrode substrate, working, ref-
erence, and counter electrodes were microfabricated on a 4-inch-diameter, 650-µm-thick
Borofloat glass wafer (Mark Optics, Santa Ana, CA) through a standard lift-off process.
The lift-off process began with transparency mask (CAD/Art Services, Bandon, OR)
based contact photolithography, followed by electron-beam evaporation-based metal de-
position (180 nm of gold on 20 nm titanium for adhesion) in a VES 2550 evaporation
chamber (Temescal, Livermore, CA), and concluded with immersion and gentle soni-
cation in acetone. The chamber layer was formed from a 0.01-inch-thick PDMS sheet
(BISCO Silicones, Rogers Corporation, Carol Stream, IL) with the channel design cut
using a programmable sign-cutting tool (CE5000-60, Graphtec, Santa Ana, CA). For the
fluidic via substrate, eyelet holes were drilled through a second Borofloat glass wafer
with a 0.75-mm-diameter diamond drill bit (Triple Ripple, Abrasive Technology, Lewis
Center, OH) using a programmable CNC milling machine (Flashcut CNC, San Carlos,
CA). The electrode wafer and fluidic via substrate were diced (7100, Advanced Dicing
Technologies, Horsham, PA) into individual chips prior to assembly. The three modu-
lar layers were manually assembled in a fume hood. During the assembly, one side of
the PDMS chamber layer was corona treated with a hand-held high-frequency emitter
(BD-20AC, Electro-Technic Products, Chicago, IL) for approximately 3 seconds before
bonding to the fluidic via substrate. This assembly was allowed to rest for several min-
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utes to ensure strong bonding between PDMS and glass. Subsequently, the other side
of the PDMS was corona treated and bonded to the electrode substrate to finish device
assembly. The complete chip measured 25 mm 11 mm and harbored three individual
chambers, each with an approximate volume of 9 µL and housed an independent set of
working, reference, and counter electrodes.
The gold working electrode in each chamber of the chip was cleaned with 50 mM
H2SO4 via cyclic voltammetry, with twelve potential sweeps ranging from -0.5 to 1.3 V
(with respect to the gold reference electrode in the chamber) applied at 0.1 V s−1 with a
sample interval of 0.001 V and 10 µA sensitivity, readying it for surface passivation. After
a brief rinse with deionized (DI) water to wash away H2SO4, the gold electrodes were
passivated with 10 mM MUA (dissolved in absolute ethanol) for 2 hr. After this passi-
vation step, each chamber was immediately rinsed three times with DI water before the
CORR-LAMP reaction mix was loaded. Of note, in contrast to the 6-mercapto-1-hexanol
(MCH) monolayer employed in the Soh Lab’s previous work [218], the MUA monolayer
obviates the high-temperature annealing step to remove defects in the monolayer, thus
simplifying the chip preparation process.
5.4.5 Assembly of CORR-LAMP Reactions
The reaction was assembled within a laminar flow hood in a separate laboratory to
prevent unwanted carryover contamination. Typical reaction mix (9 µL) contained the
following: 1x Loopamp DNA Amplification Reaction Mix (20 mM Tris-HCl, 10 mM KCl,
8 mM MgSO4, 10 mM (NH4)2SO4, 0.1% Tween20, 0.8 M betaine, and 1.4 mM dNTP),
1.4 mM dUTP, 0.2% BSA, 3.2 µM of each FIP and BIP primers, 0.4 µM of each F3
and B3 primers, 0.8 µM of each LF and LB primers (see Table S1 for primer sequences),
10 µM MB, 0.64 U/µL Bst2.0 DNA polymerase, 0.005 U/µL UDG, 0.5 µL genomic
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target DNA diluted from the stock with TE buffer to obtain the desired concentration,
and 0.4 µL simulated contaminant DNA diluted from previous LAMP reactions with
TE buffer to obtain the desired concentration. Of note, during the reaction assembly,
the reagents were kept cold with a 96-well PCR cold block (Eppendorf, Hauppauge,
NY). Also, the two enzymes were only added after other reagents have been assembled
and well mixed (except for targets and contaminants) in order to ensure their optimal
activities. Finally, simulated contaminant DNA was added in a fume hood in a separate
laboratory to prevent exposing the reaction preparation facility with unwanted carryover
contamination.
5.4.6 Dose Estimation for Carryover Contamination.
The mass yield of the LAMP reaction generated from 1× 103 copies of target in the
absence of UDG, which served as the source of carryover contaminants, was conservatively
estimated to be 0.25 g/L, as typical LAMP reactions can generate up to 0.4 to 0.8 g/L
of DNA amplicons. This source reaction was diluted by 1×108 to 1×1012-fold and 0.4 L
of the diluted product was spiked in each UDG-LAMP reaction. The mass of carryover
contaminant therefore corresponds to approximately 1× 10−15 to 1× 10−19 g.
5.4.7 UDG-LAMP Reaction Conditions and Detection.
UDG-LAMP reactions were conducted in standard Eppendorf PCR tubes and in a
bench-top thermocycler (DYAD 220 Peltier Thermal Cycler, MJ Research, Inc., Waltham,
MA), first at 25 ◦C for 5 min and then at 65 ◦C for 60 min. Upon completion of the
reaction, each sample was immediately evaluated without opening the reaction tube. Al-
though calcein fluorescence can be clearly observed by naked eye under ambient light,
images acquired under UV illumination within an imaging system can be more consistent
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due to the suppression of uneven background lighting. We therefore imaged each tube
with a Kodak Gel Logic 200 imaging system equipped with Kodak molecular imaging
software (Carestream Health, Rochester, NY) with a single exposure at 0.01 s exposure
time.
5.4.8 Gel Electrophoresis.
Amplified UDG-LAMP products were analyzed via gel electrophoresis using a 2%
agarose gel pre-stained with 1 GelStar (Lonza). Each sample consisted of 1 µL LAMP
reaction product, 2 µL 10 bromophenol blue loading dye, and 7 µL 1 TBE. In parallel,
each lane of ladder contains 1 µL low molecular weight DNA ladder, 2 µL loading dye,
and 7 µL 1 TBE. Electrophoresis was performed in 1 TBE buffer at 140 V for 40 min.
Gel images were taken with Kodak Gel Logic 200 imaging system.
5.4.9 Experimental Procedure of CORR-LAMP
Assembled reaction mix was pipette-loaded into MUA-passivated and DI-water-rinsed
microfluidic chip. The chip fluid ports were sealed with PCR film (Microseal ‘B’ Adhesive
Seals, Bio-Rad, Hercules, CA) to prevent reaction contamination and reagent evapora-
tion. The chips were connected to a potentiostat (CHI 660D, CH Instruments, Austin,
TX) for electrochemical measurements via custom card-edge connectors. After the 5-min
UDG treatment step at room temperature, the chip was placed on a digital block heater
(VWR International, Radnor, PA) maintained at 66 ◦C to perform the LAMP reaction.
The thermal contact between the chip and the heater was established by a thermal com-
pound (Arctic Alumina, Arctic Silver, Inc., Visalia, CA), which also served as an adhesive
to keep chips attached to the heater during the reaction. We simultaneously initiated a
series of time-course electrochemical measurements, measuring the redox current in each
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chip every minute for 60 min. Up to six samples (two chips) could be tested in a single
experiment.
5.4.10 Electrochemical Measurements
Square wave voltammetry (SWV) was selected for monitoring the MB redox current
during LAMP reactions due to its fast measurement time (approximately 4 seconds per
measurement). The SWV parameters were as followed: 0.2 V initial voltage, -0.4 V final
voltage, 0.004 V increment, 0.025 V amplitude, 100 Hz frequency, 1 second quiet time
and 100 nA sensitivity. A custom potentiostat macro command was written to enable
the simultaneous monitoring of two chips (six samples).
5.4.11 Electrochemical Data Processing
The time-course current measurements were normalized to the current value at the
end of the first minute of the LAMP reaction (i.e., t = 1 min). The normalized current
trace was plotted and further processed with Origin 8.0 data analysis and graphing soft-
ware (OriginLab, Northampton, MA). The normalized current trace was smoothed by
the Origin built-in five-point adjacent averaging function. The derivative curve was sub-
sequently calculated from the smoothed current trace using the Origin built-in derivative
function. The derivative trace facilitated the reliable identification of the signal threshold
—designated as the local minimum of the current derivative trace —and the correspond-
ing time-to-threshold —defined as the reaction time required for a particular sample
reaction to reach the signal threshold.
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Appendix A
Supplementary Data for
Closed-Loop Infusion Control
A.1 Pump output during controlled single-set-point
targeting
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Figure A.1: Infusion rate of DOX for three rabbits undergoing feedback-controlled
infusion targeting an identical set-point (0.5 µM for 1 hr). These infusion profiles
correspond to the control results shown for (top) Rabbit 2 in Figure 2.9B, (center)
Rabbit 1 in Figure 2.9B, and (bottom) the right-hand plot for Rabbit 5 in Figure
2.10B.
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Appendix B
Supplementary Data for
Shape-Based Sorting with FACS
B.1 4-D Gates for particle sort
Figure B.1: 4-D gate AR 1.0
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Figure B.2: 4-D gate AR 2.0
121
Figure B.3: 4-D gate AR 3.0
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Figure B.4: 4-D gate AR 4.5
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